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ABSTRACT
Neurodegeneration (cell death) is a feature of many neurological
diseases including human temporal lobe epilepsy (TLE). Recently, it has been
suggested that excitotoxicity, a process by which neurons are killed by
prolonged or excessive exposure to glutamate or its analogs, may contribute to
neuronal

injury

observed

neurodegeneration.

in

many

diseases

characterized

by

Thus, in a model of TLE, the potent glutamate analog

kainate has been shown to induce seizures and subsequent cell death in rat
hippocampus. Although the pathology produced with this model resembles
that observed in human TLE, it does not completely replicate it.
Accumulating evidence now suggest that activity of the Na+/K+-ATPase
enzyme (Na+/K+ pump), the ion pump responsible for neuronal ionic
homeostasis,

may

be

compromised

or

neurodegenerative diseases, particularly in TLE.

insufficient

in

many

In this thesis project, the

hypothesis that a reduction of Na+/K+ pump capacity will reduce neuronal
survival of excitotoxicity and produce a pathology in young adult rats similar
to that observed in human TLE was investigated.
To test this hypothesis, brain Na+/K+pump capacity was partially
inhibited in young adult rats treated with subtoxic dose of kainate.

Seizure

activity in these animals was verified by electroencephalography (EEG) and
damage to the hippocampus was documented by a silver staining method for
dead/dying neurons. Control animals were treated with either kainate or the
Na+/K+ pump inhibitor, ouabain, alone.
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In further studies, the chronic pathological and behavioral consequences of
these treatments were determined.

The following features of human TLE

were studied in these animals: 1) a pattern of cell death in the hippocampus
described as Ammon's horn sclerosis; 2) spontaneous, recurrent seizures; and
3) evidence of hippocampal remodeling.
Results of these experiments revealed that partial inhibition of the
Na + /K+pump in young adult rats with ouabain was not itself neurotoxic.
This treatment, however, markedly potentiated ordinarily subtoxic doses of
the glutamate analog, kainate.

Thus, rats treated with intraperitoneal (i.p.)

injections of kainate (5 mg/kg; i.p.) followed by intraventricular (i.c.v)
ouabain (3 nmoles) experienced behavioral and EEG recorded seizures.
Subsequent silver staining of the brain of these animals showed hippocampal
damage. In contrast, ouabain alone or kainate alone did not produce seizures
or hippocampal damage (p < 0.001; chi-square analysis). These results were
replicated with intraperitoneal injections of both kainate (7 mg/kg; i.p.) and
ouabain (1 mg/kg; i.p.). Furthermore, Na+/K+pump impairment was found
to be associated with kainate treatment in producing seizure activity and
subsequent neuronal death.

Thus, when ouabain (3 nmoles; i.c.v) was

delayed (90 min instead of 30 min) after kainate (5 mg/kg; i.p.), seizure onset
was also delayed and seizure duration was reduced. Finally, treatment with
the combination of ouabain and kainate produced features commonly
observed in human TLE:

i) acute limbic type seizures; ii) a pattern of cell

death in the hippocampus replicating that observed in the human disease; iii)
a chronic epileptic state characterized by spontaneous, recurrent seizures;

Ill
iv) evidence of plasticity and hippocampal remodeling.
The results of this study demonstrated a critical role for the Na+/K+
pump in neuronal survival of excitatory stimuli.

The hypothesis that

reduction of Na+/K+ pump capacity decreases neuronal threshold for
hyperexcitability and injury was supported, producing a seizure syndrome
and pathology in adult rats closely replicating human TLE.
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INTRODUCTION

Neurodegeneration and Temporal Lobe Epilepsy
Human Epilepsy is a significant public health problem affecting
approximately 2/1000 persons (Booss, 1995).

This illness is particularly

frequent in children where convulsions may lead to brain damage and
subsequent seizure activity in adulthood. In the adult population, temporal
lobe epilepsy (TLE) is the most common and devastating form of epilepsy.
Synonyms of this type of epilepsy include limbic seizures, psychomotor
epilepsy and complex partial seizures, deriving from the fact that it originates
from the limbic structures of the brain, i.e., hippocampus, amygdala, and
other limbic structures.

Clinical manifestations of TLE

include sensory

symptoms, visual or auditory hallucinations, visceral symptoms such as
chewing and salivation, and somatomotor symptoms including tonic-clonic
movements.

The disorder is often extremely resistant to currently available

anticonvulsant drugs. When uncontrolled, attacks may predispose to bodily
injuries and sometimes life-threatening situations (DeLorenzo, 1991).
In 1880, Sommer (Sommer, 1880) published a landmark paper
entitled "Disease of Ammon's Horn as an Aetiological Factor in Epilepsy."
This paper carried the description of the pattern of histological damage now
known as Ammon’s horn sclerosis or hippocampal sclerosis. In the brain of
these patients, principal pyramidal neurons of hippocamapus CA1 - CA4
subfields as well as dentate hilar cells (Figure 1; next page) were variably
destroyed. More recent studies of surgically obtained brain specimens have
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A. Human Hippocamous

B. Rat Hippocampus
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Figure 1: A. Schematic drawing of transverse section of human hippocampal
formation.
Pyramidal cells of area CA1 - 4 are depicted in the pyramidal layer
(py).

Dendrites of the pyramidal cells radiate into the stratum

oriens (or), stratum radiatum
stratum moleculare

(mol).

(rad), stratum lacunosum

(lac), and

The dentate hilus is the area of cells

circumscribed by the granule cells in the dentate gyrus. The mossy
fibers (mf; axons of granule cells) making synaptic connection with
pyramidal cells of area CA3 are shown. Synaptic connections also
exist between pyramidal cells via the Schaffer collaterals (Sch). The
major afferent pathway to the hippocampus is the perforant
pathway (pf). This pathway is excitatory and synapses with granule
cells. Efferent fibers leaving the hippocampus in the fornix (fo) are
axons of pyramidal cells.
B. Transverse section through rat hippocampus.
The overall organization of the rat hippocampus is very similar to
that of human. Areas CA1 - 3 are shown. The hilar region
corresponds to area CA4 in human hippocampus. Afferent and
efferent

pathways

(not

shown)

are

also

similar.

(Other

abbreviations: Dentate hilus (Hi). (Brodl, 1980; Paxinos and Watson,
1986).
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confirmed Sommer's findings (Margerison and Corsellis 1966; Corsellis and
Bruton, 1983; Babb et al., 1984; de Lanerolle et al., 1992).

This type of

irreversible neurodegeneration is not a feature of TLE alone;
reported for
Huntington's

it has been

many other chronic neurological conditions such as
chorea,

Alzheimer's

disease,

and

Parkinson's

disease

(Margerison and Corsellis, 1966; Babb et al., 1984; Meldrum, 1985; Rothman
and Olney, 1987; Choi, 1988b; Lees, 1991; de Lanerolle et al., 1992). Whether
the neurodegeneration observed in the brain of patients suffering from TLE is
the cause or effect of this disease is a century-old debate.

More recently,

however, there has been considerable effort to understand the pathogenesis of
cell death in TLE.

It is hoped that elucidation of such mechanisms would

provide means to prevent or ameliorate this potentially debilitating disease.
In 1980, the work of Wyllie and his colleagues suggested that most cell
death could be separated on the basis of morphology into "apoptosis" and
"necrosis" (Wyllie et al., 1980).

Apoptosis is characterized by an initial

condensation of cellular and nuclear elements. This is followed by a process
of cytoplasmic vacuolization. Membrane permeability and organelle integrity
are preserved, but cells become detached from adjacent cells and form
apoptotic bodies.

Examples of apoptosis include normal programmed cell

death, glucocorticoid-induced death of immature thymocytes, and radiation
cytotoxicity. Wyllie and his co-workers suggested that the pathophysiology of
apoptosis might involve endonuclease digestion of nuclear chromatin.

On

the other hand, necrosis describes cell death that is marked in the early stages
by chromatin clumping, progressing with swelling of mitochondrial matrix,
and terminating with eventual rupture of nuclear, organelle, and plasma
membranes.
ischemia,

Examples of necrosis include cell death induced by hypoxia-

toxins,

or

complement.

It

has

been

suggested

that

the
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pathophysiology of necrosis involves loss of cellular volume homeostasis
secondary to altered membrane permeability, as evidenced by abnormal
permeability to dyes or chromium (Wyllie et al, 1980).

EXCITOTOXICITY
An interesting discovery of modern neuroscience research is that
excitatory amino acids (EAA) such as glutamate and its analogs (e.g. kainate)
can kill neurons after brief, intense exposure (Rothman, 1985; Choi et al.,
1987).

This phenomenon has been termed excitotoxicity (Olney, 1986). The

exact morphological features of the cell death induced by this mechanism
remains to be classified either as necrotic, apoptotic, or a combination of both;
however, there is increasing evidence to suggest that this mechanism
participates in the pathogenesis of many neurodegenerative conditions
including stroke, epilepsy, and Parkinson’s disease (Choi, 1992),
The first in vivo evidence of excitotoxicity were noted more than 20
years ago. In these studies, characteristic pathological changes were noted in
the circumventricular regions of young monkeys and rodent brains treated
with high systemic doses of glutamate (Olney, 1969; Olney et al., 1972).
Within 30 min of glutamate administration, acute neuronal swelling was
noted by electron microscopy.

Subsequently, neurons became necrotic and

underwent phagocytosis by macrophages over the next several hours.
Similarly, kainic acid, literally meaning the ghost of the sea in Japanese
(Takemoto, 1978), is a potent analog of glutamate (Shinozaki and Konishi,
1980; Shinozaki, 1981) that has been shown to produce "axon-sparing lesions"
in rat brain (Coyle et al., 1978).

The use of kainate to circumvent the

destruction of fibres de passage (axons which were destroyed by conventional
electrolytic lesions) led to studies that have provided several experimental
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models of human diseases such as hemiballism (Hammond et al., 1979),
Huntington's chorea (Coyle et al., 1981), and human TLE (Ben-Ari et al., 1981).
The association between excitotoxicity and neuronal death in human
neurodegenerative diseases has come mainly from indirect evidence
(Meldrum, 1985; Rothman and Olney, 1987; Choi, 1988).

In one particular

study, brain extracellular concentrations of excitatory amino acids were
sampled by microdialysis in conscious epileptic patients. This study
demonstrated that extracellular glutamate levels increased significantly prior
to seizure episodes and remained elevated during seizure activity, reaching
potentially neurotoxic concentrations in the hippocampus (During and
Spencer, 1993).
Transmembrane ion imbalances created by excitotoxicity kills neurons
In

vitro

experiments

using

cultured

cells

and

patch-clamp

methodology have helped to elucidate the interaction between EAA's and
cortical cells during excitotoxicity. When neurons are exposed to glutamate
or its agonists, there is an immediate depolarization accompanied by Na+
influx and K+ efflux.

Additionally, a Ca++ influx is detected on prolonged

neuronal exposure to glutamate.
identification of

These and other studies have led to the

two components of excitotoxicity.

During the first phase,

there is an influx of Na+ that is accompanied passively by influx of Cl" and
water, leading to cell swelling (Rothman, 1985; Choi et al, 1987). This phase
need not be toxic to the cell;

volume homeostasis may be regained if the

excitatory insult is removed (Choi, 1992). If cells continue to be exposed to
glutamate, a second set of events occur that is marked by delayed neuronal
disintegration beginning several hours after initial exposure.

This phase is

7
most likely triggered by excessive Ca++ influx into the cell, since it is
dependent on the presence of extracellular Ca++ (Choi, 1985).
In summary, profound and potentially toxic ionic changes take place
both inside and outside the cell milieu after brief or prolonged intense
exposure to glutamate and other excitatory amino acids.

Excessive or

repetitive stimulation may lead to cell death (Lowe, 1971; Choi, 1985;
Rothman, 1985; Mayer and Westbrook, 1987; Rothman and Olney, 1987).
These observations have suggested that neuronal mechanisms for ionic
homeostasis may be overwhelmed during excitotoxicity.

THE Na+/K+ PUMP
The sodium/potassium ATPase (Na+/K+-ATPase; Na+/K+pump) is a
transmembrane protein of ubiquitous distribution in mammals.

Both

human and rat brains are especially enriched with this pump ( Brines et al.,
1991; Mata et al., 1991; Watts et al., 1991; Brines and Robbins, 1993).

Even

under resting conditions, at least 60% of the energy released by respiration is
consumed by brain ATPase, compared with about 5% in liver and striated
muscle (Lowe, 1971; Ritchie and Straub, 1980; Astrup et al., 1981; Choi, 1985;
Hansen, 1985; Rothman, 1985; Mayer and Westbrook, 1987; Rothman and
Olney, 1987).
The Na+/K+-ATPase is a heterodimeric enzyme (Figure 2; next page)
consisting of a large catalytic (a) subunit (-115 kD) and a smaller glycoprotein
((3) subunit (-45 kD). Currently three catalytic isoforms (al, a2 and a3) with
two glycoprotein isoforms ((31, (32) are recognized (Shull, 1986; Shull, 1987;
Young, 1987). Tissue-specific isoform distribution exists for some isoforms of
this pump. Thus, the a3 isoform is virtually exclusive to the nervous system
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FIGURE 2: The Na+/K+-ATPase enzyme
This enzyme consists of a large catalytic (a) subunit (~ 115 kD) and a smaller
glycoprotein ((3) subunit (~45 kD). Currently three catalytic isoforms and two
glycoprotein isoforms are recognized (Young et al., 1987; Shull et al., 1986).
Ouabain binds reversibly to the K+ binding site.
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and is expressed at very high levels by neurons (Schneider et alv 1988; Filuk et
al., 1989; Brines et al., 1991; Watts et al., 1991). Regional as well as cell typespecific distribution also exist for pump isoforms (Caspers et al., 1987; Brines
et al., 1991).

The olfactory nuclei, dentate gyrus, hippocampus are among

brain regions expressing the highest levels of the Na+/K+ATPase enzyme.
The large neurons of the olfactory bulb and pyriform cortex express high
levels of a3 and lesser levels of al mRNA.
hippocampus express all

three isoforms;

Principal cells of the

however,

the

a3

mRNA

predominates. Finally, the distribution of functional Na+/K+ATPase enzyme,
as localized by [3H] ouabain binding, is highest in the neuropil of
hippocampus and cerebral cortex and lower over perikarya and white matter,
reflecting higher expression of pump activity by neurons.
The Na+/K+ pump provides several critical functions for the cell
(Figure 3; next page), (reviewed by Skou, 1988). This pump is responsible for
restoring transmembrane gradients of Na+ and K+ after neuronal excitation.
In experiments on vagus nerve energy metabolism, the increased glucose
metabolism resulting from stimulation of the nerve is largely used for
restoring the ionic gradient across the cell membrane.

This increase in

glucose utilization is blocked by the Na+/K+-ATPase inhibitor ouabain
(Yarowsky and Ingvar, 1981). The pump also provides the energy required for
driving other transport mechanisms including Na+/Ca++ exchange and
uptake of many small molecules such as glucose and excitatory amino acids
(e.g. glutamate).

In a recent study with glial cultures and rat brain

synaptosomes, uptake of glutamate was sodium-dependent, driven by the
transmembrane gradient established by the Na+/K+pump. (Barbour, 1988;
Erecinska, 1989). Further evidence also supports a role for both glia and
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FIGURE 3: Multiple ionic homeostatic mechanisms of the Na+/K+-ATPase
enzyme family: The Na+/K+-pump buffers effects of stimulation (e.g., by
glutamate) via direct (uptake of K+ and extrusion of Ma+) and indirect
(maintainance of sodium gradient for glutamate uptake and extrusion of
Ca++) mechanisms.
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neuronal Na+/K+ATPase in buffering potential glutamate toxicity in rodent
cultures (Rosenberg, 1991; Rosenberg et al., 1992).

Lastly, but not least, this

pump plays the important role of maintaining cellular integerity by
regulating cell volume (Lowe, 1971; Ullrich, 1979; Stahl, 1986; Skou, 1988;
Horisberger et al., 1991).
An interesting feature of the Na+/K+-ATPase is that it holds
tremendous reserve capacity such that it is able to compensate for increased
requirement for Na+ transport by increased enzymatic activity.

The exact

mechanisms of this upregulation are still being investigated.

However,

unlike the sodium-impermeable glia, neurons possess a significant sodium
permeability at rest (Kuffler et al., 1984) and, not surprisingly, express the
majority of brain Na+/K+ pump (Brines et al., 1991; Mata et al., 1991).

At

resting metabolic activity the extracellular K+ site of the pump is saturated
and intracellular Na+ is present at non-saturating concentrations (Jorgensen
and Skou, 1969; Skou, 1988).

Under these conditions, the pump operates at

~20 - 25% of its maximum capacity (Vmax) (Skou, 1988).

Experiments in

synaptoneurosomes have demonstrated that maximum Na+/K+ capacity is
only half achieved when maximum demand for ion transport is imposed.
Thus, when the sodium ionophore, monensin, was used to increase
intracellular Na+ to levels equivalent to that in the extracellular milieu, a less
than 50%

increase in ouabain-inhibitable rubidium pumping (a measure of

ATP-ase-regulated K+ influx) was observed (Swann, 1991). Further evidence
from membrane experiments suggest that Na+/K+-ATPase response to small
increases in intracellular Na+ concentrations may occur on the order of
seconds (Skou, 1988). Despite the tremendous ionic homeostatic mechanisms
subserved by the Na+/K+ ATPase, neuronal injury is a constant consequence
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of excitotoxicity.

One possibility is that Na+/K+ pump capacity may be

insufficient or compromised during excitotoxicity.

Evidence for reduced Na+/K +ATPase capacity in epilepsy and other energy-deficient
states.
In the past, it has been argued that the regional increase in blood flow
accompanying seizure activity precludes ischemia that would significantly
decrease cellular ATP concentrations (Meldrum, 1983; Ben-Ari, 1985; Auer
and Siesjo, 1988).

More recently, studies by Brines and co-workers have

revealed that reduced levels of cytochrome c oxidase activity may be present
in epileptic hippocampi (Brines et al., 1995) . This enzyme is the main source
of energy substrate for the Na+/K+-ATPase (Dagani and Erecinska, 1987). It is
estimated

that ATPase activity is significantly reduced when ATP

concentration declines below 0.4 mM (ibid). Thus, intrinsic defects in cellular
energy metabolism, rather than external factors such as ischemia alone, may
adversely impact Na+/K+ ATPase activity in epileptic hippocampi.
Arachidonic acid, other long-chain fatty acids, lysophospholipids and
prostaglandins accumulate during seizure activity (Siesjo et al., 1982).

All

these compounds are known potent inhibitors of the Na+/K+pump (Baran et
al., 1987); arachidonate being the most potent. At concentrations of 0.1 - 0.4
mM this fatty acid is sufficient to cause over 90% inhibition of the Na+/K+ATPase in the cortex (Chan et al., 1983; Swann, 1984). During seizure activity
free fatty acids including arachidonate increase to a level enough to inhibit
-40% of total brain Na+/K+ pump capacity (Siesjo et al., 1982; Yoshida et al.,
1987).
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An integral component of the Na+/K+-ATPase is a phospholipid
moiety that binds with high affinity to calcium and is required for pump
activity (Charnock et al., 1975; Abeywardena and Charnock, 1983).

It is

reported that up to 10% of cellular phospholipids are degraded during seizure
activity.

In particular, phosphotidylinositol and polyphosphoinositide, the

major phospholipids essential for pump activity, are most vulnerable (Eiselet
et al., 1984; Yoshida et al., 1986; Abe et al., 1987).

Arguably then, several

mechanisms including those described above may contribute to the neuronal
death associated with seizure activity by directly or indirectly impairing
Na+/K+-ATPase activity.

Hypothesis
It has been suggested that the Na+/K+pump is probably the single most
important ion pump in the cell (Lees, 1991), playing the critical homeostatic
role of maintaining the transmembrane ion gradient responsible for
excitability and integrity of the neuron. Yet, the role of the Na+/K+ pump in
modulating nervous system activity and, particularly, in seizure generation
and maintenance is only poorly characterized.
A model of how the Na+/K+ pump may interact with the process of
excitotoxicity is summarized in Figure 4 (next page).

At resting states,

endogenous levels of glutamate and its analogs (e.g. kainate) act via specific
receptors to depolarize neurons.

Such depolarization leads to Na+ influx

(followed passively by CL) and K+efflux.

Ordinarily, the Na+/K+ pump

functions to maintain transmembrane ionic equilibrium by rectifying these
disturbances.

When chronic hyperstimulation occurs due to chronic or

intense exposure to EAA, Na+/K+ pump capacity may be overwhelmed.
Sodium may accumulate in the cell, cell swelling results, and irreversible cell
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Na+/K+ pump

EAA

Na+, Cl", Ca++
h2o

/

Cels

\

Death

\
|

FIGURE 4: EXCITOTOXICITY
Ordinarily, the Na+/K+ pump rectifies ion imbalance due to innocuous levels
of excitatory amino acids (EAA). However, prolonged or intense stimulation
may overwhelm the Na+/K+ pump and cell swelling may ensue with eventual
cell death.
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injury ensues. Based on this model, it was hypothesized that:
Impairment of brain Na+/K+ pump capacity will decrease neuronal
survival of excitatory stimuli.
Some experimental evidence exists in support of this hypothesis.
Novelli

and

co-workers

(Novelli

et al.,

1988)

examined

neurotoxicity using cultured neonatal cerebellar granule cells.

glutamate
Specifically,

they examined the ATP dependence of glutamate toxicity and observed that a
variety of treatments, including 1 pM ouabain, potentiated subtoxic
concentrations of glutamate.

However, this experiment has limited

application to excitotoxicity for several reasons. First, their experimental
model consisted of a single neuronal type which is relatively insensitive to
glutamate. Also, Na+/K+ pump mRNA mapping studies suggest that
cerebellar cells may possess only the al isoform of the pump which is
relatively insensitive to ouabain at 1 pM concentrations.
Brines and co-workers have also tested this hypothesis in vitro . Using
fetal telencephalic cultures, a2/a3 isoforms of the Na+/K + pump were
inhibited with low concentrations of ouabain (1 pM).

Under these

conditions, total sodium pump activity was reduced by 65% as accessed by
rubidium-uptake (Brines and Robbins, 1992).
neurotoxic under basal conditions.

This treatment was not

However, when cultures were

subsequently subjected to the additional stress of normally non-toxic levels of
glutamate (100 pM), neurons were preferentially destroyed.
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THESIS PROPOSAL
Although evidence from in vitro studies lend support to the concept
that the Na+/K+-ATPase is critical to neuronal survival of excitotoxicity,
several obvious limitations exist in trying to understand human pathological
processes on the basis of in vitro findings. First, cultured cells derived from
fetal tissue may behave differently from adult cells.

Furthermore,

experiments in vitro are conducted in isolated systems and therefore do not
account for the complex interactions that may take place with other systems
in vivo.
The principal goal of this project was to test the hypothesis that
reduction of Na+/K+ pump capacity will limit neuronal survival of excitatory
activity in vivo and produce a pathology in young adult rats similar to that
observed in human TLE.

The kainate rat model was conveniently adopted

for this purpose. The seizure syndrome and subsequent pathology induced by
the potent glutamate analog, kainate, in rat has been extensively studied and
shown to possess some features of human TLE:

1) The hippocampus,

amygdala and other limbic structures play a central role in the seizure
syndrome induced by kainate acid (Schwob et al., 1980; Ben-Ari et al., 1981;
Lothman and Collins, 1981). 2) Spontaneous, recurrent limbic type seizures
are reproducibly observed after parenteral (Tremblay and Ben-Ari, 1985) or
intracerebral administration of kainic acid (Cepeda et al., 1982; Cavalheiro et
al., 1983). 3) Anticonvulsants are weak against the seizures generated by kainic
acid (Stone and Javid, 1980; Clifford et al., 1982).

However a number of

important differences exist between the kainate model and the human
pathology. Pyramidal cells of hippocampus subfield CA1 are destroyed in the
human pathology (Margerison and Corsellis, 1966; Corsellis and Bruton, 1983;
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de Lanerolle et al., 1992 and 1994). These are not routinely destroyed in the
kainate model. Damage to these cells is achieved only with very high doses
of kainate, leading to high animal mortality.

Moreover, unlike the human

pathology in which neuronal damage is mostly confined to the hippocampus,
kainate induces extrahippocampal damage in the amygdala, pyriform cortex,
entorhinal cortex, and thalamus.
Thus, several potential benefits existed for testing the above stated
hypothesis in the kainate rat model. First, it allowed verification of results of
previous in vitro

investigations of this hypothesis (Novelli et al., 1988;

Brines and Robbins, 1992).

Second, successful reproduction of the human

pathology by impairing Na+/K+pump capacity in the kainate model would 1)
provide experimental, in vivo support for Na+/K+-ATPase insufficiency or
dysfunction in the neuropathology of human TLE, and 2) provide an animal
model which may be used as a tool for further investigation of human TLE.
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METHODS AND MATERIALS

EXPERIMENTAL DESIGN
This study consisted of two parts: A direct test of the experimental
hypothesis was carried out in three steps in part one. First, a subtoxic dose of
kainate (a dose of kainate not producing seizures and/or neurotoxicity in
young adult rats) was determined.

Subsequently, conditions for partial

impairment of brain total Na+/K+pump capacity were established. In a final
step to test the hypothesis, Na+/K+ capacity was impaired after treating rats
with a subtoxic dose of kainate. In part two, the behavioral and pathological
consequences of Na+/K+pump inhibition in kainate-treated animals were
characterized.

PARTI
1) DETERMINATION OF A SUB-TOXIC DOSE OF KAINATE
Response to the glutamate analog, kainate, is very variable in different
animals and even within animals of the same species (Ben-Ari, 1985; Sperk,
1994).

Factors such as species of animal, commercial breeder, inter-species

variations (e.g. sex, age and weight) and route of drug administration may
influence response to kainate.

Therefore, to establish a subtoxic dose of

kainate it was necessary to derive this from a dose-response curve.

This

curve was achieved by administering a wide range of experimentally reported
doses of kainate (3 - 12 mg/kg body weight) intraperitoneally (IP; i.p.) and
observing animals for overt behavioral seizures. Twenty-four hours after the
start of experiments, animal brains were sacrificed and their brains were
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removed and examined for cell death in the hippocamapus, using a
technique of silver staining that stains for dead/dying neurons.

2) PARTIAL IMPAIRMENT OF TOTAL BRAIN Na+/K + PUMP CAPACITY

The Na+/K+ ATPase is essential for the maintenance of cellular
integrity of neurons and glia.

Therefore, complete inhibition of the Na+/K+

pump with high concentrations of ouabain is toxic to neurons (Lowe, 1978;
Garthwaite et al., 1986; Lees et al., 1990) . However, unlike most mammalian
Na + /K+ATP-ase which possess high affinity (10-9 - 10*8M) for glycosides,
rodents al isoform has a low affinity (10-4 - 10'3M) for ouabain, and thus is
less sensitive to ouabain inhibition (Sweadner 1989; Brines and Robbins 1992).
Consequently, it is possible to titrate glycoside concentrations to achieve
partial inhibition of the Na+/K+ pump.
Previous experiments in cultured telencephalic cells by Brines and co¬
workers have shown that -65% reduction of total Na+/K+ pump activity (as
assessed by rubidium up-take studies) is achieved with ouabain (1 pM)
(Brines and Robbins, 1992). Assuming a uniform distribution throughout the
volume of brain extracellular fluid (Kuncz et al., 1990), it was estimated that
ouabain (3 nmoles) attains -0.5 - 1 pM ambient brain concentrations.
However, ouabain crosses the blood-brain barrier (BBB) very poorly (Dutta
and Marks, 1966; Dutta et al., 1977). Therefore, to ensure that ouabain reaches
the brain at desired concentrations it was administered intracerebrovascularly
(ICV; i.c.v) through surgically implanted infusion ports (cannula).

The level

of Na+/K+ pump inhibition achieved with ouabain was assessed by [3H]
ouabain binding studies.

Potential epileptogenic effects of ouabain were

monitored by intrahippocampal electroencephalographic (EEG) electrodes
implanted at time of surgery for cannula placement. Animals were sacrificed

20
24 hours after the start of experiments and potential neurotoxic effects of
ouabain

were studies

using

the silver

stain

technique.

In

control

experiments, animals were treated with artificial cerebrospinal fluid (CSF).

3) DOES PARTIAL IMPAIRMENT OF Na+/K+-ATPase AMPLIFY KAINATE
NEUROTOXICITY?

After establishing steps 1 & 2 above, these conditions were combined to
test the proposed hypothesis. Animals were treated with a sub-toxic dose of
kainate

(i.p.) followed later by ouabain

(i.c.v.).

Since ouabain was

administered directly into the brain, it was delayed by 1/2 h to allow adequate
CNS penetration by kainate.
document seizure activity.

Intrahippocampal EEG was recorded to

Subsequently, animal brains were examined for

neuronal damage. Control animals received either kainate or ouabain alone.
In additional experiments, the time of ouabain administration after kainate
injections was varied from 1/2 h to 11 /2 h to further investigate the
association between ouabain and kainate in producing seizures.
Experiments were repeated using intraperitoneal injections of both
kainate and ouabain. According to estimates of volume of body distributions
in young rats, ouabain (~ 1 mg/kg; i.p.) produces plasma concentrations in the
range of 1 jiM (Watkins et al, 1987; Tatsuji et al 1982).

In experiments in

which systemic and CSF levels of [3H]ouabain were monitored over a 60 min
period after intravenous (IV; i.v.) administration of this drug, plasma/CSF
ratio for ouabain remained at ~ 1: 40, although CSF appearance of the drug
was delayed by ~ 10 min (Dutta et al., 1977).

Thus in intraperitoneal

experiments, ouabain was administered first and followed by kainate at 15
min interval due to the less effective CNS penetration of ouabain.

Even with
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a delay in kainate administration, it was expected that kainate would attain
appreciable levels in the brain prior to ouabain.

PART II
CHARACTERIZATION OF THE SEIZURE SYNDROME AND NEUROPATHOLOGY IN
Na+/K+PUMP-IMPAIRED, KAINATE-TREATED RATS

Three features of human TLE were investigated in Na+/K+ pump
impaired, kainate-treated animals :

1) The pattern of hippocampal cell death

was characterized by the silver staining method for dead/dying neurons. 2)
The presence of a chronic epileptic state was documented by observing
animals for spontaneous, recurrent seizures over a period of 30 - 90 days. 3)
Histological evidence of plasticity and remodeling in the hippocampus was
determined by the Timm stain technique at 30 and 90 days after initial
experiments.
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METHODOLOGICAL DETAILS

Animals and Materials
Adult male Sprague-Dawley rats weighing 250 - 300g were used in these
experiments (Charles River Breeders).

Animals were housed at the Boyer

Animal Center (Yale University, School of Medicine) under 12 hr light/ dark
cycle and provided with food and water ad lib.

Animal surgery was

performed using Kopf stereotactic frames (Kopf Instruments) and the
coordinates of Paxinos and Watson (1986). Animals were anesthetized with a
mixture of xylazine (20mg/ml; Butler Co.) and ketamine (100 mg/ml; Benny
Schein).

Ouabain (Sigma, Chemical Co.) was administered into to right

lateral cerebral ventricle using a slow-infusion pump (Harvard apparatus)
connected by tubing to a cannula system implanted into the right lateral
ventricle of the animal.
experiments.

A standard infusion rate (1 pl/min) was used in all

A stock concentration of ouabain (0.333 nmol/pl) was prepared

in artificial CSF (NaCl: 135 mM; KC1: 3 mM; MgCl2 : 1 mM; CaCl2 : 1.2 mM;
ascorbate: 200|iM; and sodium mono- and dibasic phosphate: 2 mM to pH 7.4)
stored at -20 °C, and thawed freshly prior to use. Kainic acid was dissolved in
normal saline (0.9%, w/v, NaCl in distilled H20)

and administered

intraperitoneally.

Animal Surgery

(i) Cannula Placement
Five

to

seven

days

prior

to

experiments,

animals

underwent

stereotactic cannula placement into the right, lateral ventricle (AP = -0.3, L=
+1.4, V= - 3.0).

Animals were anesthetized with a mixture of ketamine/

xyalzine (8/80 mg/kg; i.p.). After onset of anesthesia, animals were placed in
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a kopf stereotactic frame, hair over the cranium was shaved, and the scalp
was sterilized with alcohol and betadine.

A subcutaneous injection of

epinephrine/lidocaine was administered to provide local anesthesia and
hemostasis.

A

longitudinal

incision

was

then

made

in

the

approximately 2 cm long from the coronal suture to the lambda.

scalp
The

cranium was exposed after blunt dissection of the subcutaneous tissue. After
marking the desired stereotactic coordinates using bregma as reference, the
skull was drilled with a 0.80 screw on a hand-held drill (Plastics One, Inc.). A
pre-cut guide cannula was stereotactically placed approximately 2 mm above
the right ventricle and secured to cranial screws using Loctite glue (Bearing
Distributors).

The exposed cranium was then covered with a hygenic repair

resin (Dental Lab. Distributors) to provide additional support for the cannula
system.

The skin incision was closed with a 3-0 prolene stitch.

A "dummy"

cannula was advanced through the guide cannula into the right ventricle and
left in place for the animals to recover from the operation (Figure 5; next
page). Correct cannula placement was verified by serial brain sectioning.

(ii) Electrode placement
In experiments in which EEG monitoring of seizure activity was
required, bilateral,

intra-hippocampal electrodes were placed at the time of

surgery for cannula implantation.

Routinely, four thin (1mm) platinum-

coated, stainless steel electrodes were placed: an active electrode in the right
hippocampus with its tip aiming at area CA3 of the hippocampus (AP = -4.2;
ML = +2.0; DV= -3.0), a second active electrode with a tip aiming at area CA3
of the left hippocampus (AP = -4.2; ML = -2.0 DV= -3.0), a reference electrode
in the left frontal area (AP = +3.0; ML = -2.0 DV= -2.0), and a ground electrode
attached to a cranial screw.

All electrodes were secured to the skull using
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Figure 5: EXPERIMENTAL SET-UP:

Five to seven days prior to experiments, animals underwent
surgery and were implanted with guide cannula (right lateral
ventricle)

and

hippocampal).

electroencephalographic

electrodes

(intra-

On the day of experiments, kainic acid was injected

intraperitoneally (IP; i.p.).

Ouabain was either injected IP or

intraventricularly (ICV; i.c.v.) through the implanted cannula.
Animals were observed behaviorally for seizures and hippocampal
activity was monitored by electroencephalography (EEG).

Twenty-

four hours after experiments, animals were sacrified and their
brains were examined for cell death using the silver staining
method. Dead cells were identified by silver staining. Cell loss was
assessed by Nissl staining.
animals were sacrified

At 30 and 90 days after experiments,

and

their brains were

observed

for

hippocampal remodeling using the Timm stain (refer to text for
detail).
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Loctite glue and subsequently with hygenic repair resin as described above.
All electrodes were brought into a "female nut" and left in place during
animal recovery (Figure 5). Correct electrode placement was verified by serial
brain sectioning.
Tissue Preparation
SILVER STAIN

The silver staining method is a staining technique used to reveal dead
and degenerating neuronal cell bodies beginning at least

8

hrs after brain

injury. Complete characterization of brain damage is best achieved with this
technique when animals are perfused 24 hrs after the initial brain injury
(Nadler and Evenson, 1983). This stain was selected so as to visualize cell
bodies primarily and not their processes.
Animals were anesthetized with chloral hydrate (50mg/kg i.p.) and
perfused trans-cardially with normal saline for 30 sec and then with 4% (w/v)
paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4, for 15 - 20 min
(200ml). The brains were then removed and fixed further in cold, buffered
paraformaldehyde for 3 days at room temperature.

Brain specimens were

embedded in 5% agarose (w/v) in 0.1 M phosphate buffer, cut into 40 pM
thick sections on a Lancer vibrotome in phosphate buffer, pH 7.4.
Details of procedure:
Reagents:

A. 9% (w/v) NaOH
B. 16% (w/v) NH4 NO3
C. 50% (w/v) Ag NO3
D. 1.2% (w/v) NH4 NO3
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E. Dissolve 5 g of anhydrous Na2CC>3 in 300 ml of 95% ethanol and 600
ml of water. Dilute to 1 litre with water.
F. Dissolve 0.5 g of anhydrous citric acid in 15 ml of 35% formalin, 100
ml of 95% ethanol, and 700 ml of water. Add solution A with
stirring

until the pH reaches 5.8 - 6.1 then dilute to 1 litre with

water.
G. 0.5% (v/v) acetic acid

Working

Solutions:

(These solutions were prepared not more than 1 hr before staining).
1. Pretreating solution: Equal amounts of solutions A & D.
2. Impregnating

Solution:

Add 1.5 volumes of solution A to each

volume of solution B. Then add 0.5 - 0.6 ml solution C (1.5 ml) for
each 100 ml of total volume.
3. Washing Solution:

Mix 1 ml of solution D with each 100 ml of

solutionE.
4. Developing Soliution:

Mix 1 ml of solution D with each volume of

solution F.

Staining Procedure:
Sections were washed free of fixatives by immersion in three changes
of water for 5 min each. Sections were then transferred sequentially into two
changes of pretreating solution for 5 min each, impregnating solution for 10
min, and finally developing solution for at least 1 min.

Sections were

mounted from developing solution onto acid-cleaned glass slides that have
been precoated with 0.5% (w/v) chromium potassium sulfate, 0.5% (w/v)
gelatin.

When the mounted sections have dried, they were immersed in

three changes of solution G for 10 min each, washed with water, dehydrated
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with a graded series of ethanol solutions, cleared with butanol and three
changes of xylene, and covered with coverslips.

TIMM STAIN

The heavy metal, zinc, is released from mossy fibres (MF) of the dentate
granule cells in the hippocampus and is also found to accumulate in injured
neurons in the hippocampus (Sloviter, 1982).

Following kainate-induced

lesions, the MF of the granule cells send out collaterals which grow across the
granule cell layer and form a plexus in the inner molecular layer of the
granule

cell

dendrites

(Laurberg and Zimmer,

1981).

This

type of

hippocampal remodeling has been termed 'sprouting' and is also observed in
human epileptic hippocampus (Babb et al., 1991; de Lanerolle et al., 1994). The
Timm technique stains for zinc and therefore is used to identify sprouting in
the injured hippocampus.
To prepare rat brains for this technique, animals were anesthetized with
chloral hydrate and perfused trans-cardially using 0.37% sodium sulphide in
phosphate-buffered solution, pH 7.2, for 5 min and with 10% neutral buffered
formalin (NBF) for 5 min.

(Sulphide in the perfusate impregnates neurons,

and it is later oxidized to sulphite in lysed cells, staining them black).

Rat

brains were removed and further fixed in NBF solution for at least 2 hrs, but
not more than 3 days.

Coronal sections (40 |iM) are cut on a Lancer

vibrotome into phosphate buffer pH 7.4, collected onto subbed-slides, and
allowed to dry at room temperature.
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Details of Procedure:
Reagents:
A. Gum Arabic Solution; 50% (w/v) gum arabic in water.
B. Citrate Solution: 9.4 g sodium citrate in water 10.2 citric acid
monohydrate in water.
C. Hydroquinone Solution: hydroquinone in water.
D. Silver Nitrate Solution:

(w/v) AgNC>3 in water.

E. Developer: Mix 250 ml of solution A, 40 ml of solution B, and 120 ml
of solution C

and warm the mixture to 26°C.

2 ml aliquot of

solution D is added just before staining.
Staining Procedure:
Slides are rinsed serially in 70% ethanol, 50% alcohol, and then in four
changes of water for 3 min each. The slides are covered with developer and
placed in a water bath maintained at 26 °C in a dark room for 45 min. Slides
are washed in tap water in the dark for 5-10 min to terminate development.
The sections are then dehydrated with graded ethanol ( 70%, 95%, 100%,
100%) and xylene for 3 min each and coverslipped for viewing under the
microscope.

NISSL STAIN

The Nissl stain is a basic neurological staining techniques that stains
for nissl granules in neuron. It was used to counter stain Timm stain to help
delineate nerve cells and neuronal architecture.
Details of Procedure:
Reagents:
Toluidine blue (stock) : 0.1% (w/v) toluidine blue in distilled water.
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Working solution:
A: 10 ml of stock toluidine blue in 10 ml of 0.1M phosphate buffer.
Staining procedure:
Slides were immersed in xylene to remove coverslips from Timm
stain procedure.

Sections were then rehydrated by serial changes through

graded ethanol (100%, 95%, 70%) for 1 min each and then washed by dipping
in water 5-10 times.

Slides were then covered with toluidine blue for 30

seconds and washed again with distilled water. After a one-minute wash in
70% acid alcohol, sections were dehydrated with graded alcohol changes (70%,
95%, 100%, 100%) for 1 min each and then through two changes of xylene, 5
min each.

Finally, slides were coverslipped for viewing under the light

microscope.

In situ f^Hl ouabain binding studies
Ouabain specifically binds only to sodium pump in an active
conformation, therefore it has been used widely to assess Na+/K+ pump
function/capacity (Hegyvary, 1976; Hootman and Ernst, 1981; Kjeldsen and
Norgaard, 1987).

In situ [3H]ouabain binding studies were carried out to

quantitate high-affinity Na+/K+ pump active sites in hippocampal sections.
Animals were sacrificed as above, and their brains were quickly removed,
blocked, and flash-frozen in embedding medium on dry ice. Brain specimens
were then stored at -70°C until use within 5-7 days.
On the day of binding studies, coronal sections (20 |iM) of the dorsal
hippocampus were cut on a Reichert cryostat (2800E) at -15 °C and thawmounted onto gelatin-potassium dichromate-subbed slides.

Sections were

dried for 2 min at 37 °C and then frozen at -70 °C Subsequently, sections were
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brought to room temperature and preincubated in TM buffer (tris-HCl 50 m,
MgCl2 10 mM, pH 7.4) for 15 mins at 27 °C to dissociate any unbound ouabain¬
like substances. Excess solution was blotted from each slide, and 1 ml of TM
buffer containing 10 nM 3H-ouabain (Dupont, NAN), 100 mM NaCl, 5 mM
ATP, with or without 1 pM cold ouabain (Sigma Chemical Co.) was layered
over each section.

Tissue was incubated at room temperature for 45 min.

Previous studies by Brines and co-workers have shown that ouabain binding
attains

equilibrium in 30 min at

min (Brines et al., 1991).

27 °C and remains constant for at least 60

To terminate ouabain binding, slides were washed

twice in ice-cold buffer for 5 min each, rinsed in deionized water to remove
buffer salts, and rapidly dried within 1 min with cool air.

Dried slides were

then exposed to Ultrofilm (Reichart, Inc.) along with appropriate tritium
plastic standards (American Radiolabeled Chemicals) and exposed for two
weeks.

EEC Studies
Brain electrical activity was recorded on a Grass

Model 6 EEG (Grass

Instrument Co.) from platinum electrodes stereotactically implanted into
hippocampi as described above. The EEG acquisition montage consisted of a
combination of monopolar and bipolar techniques.

A left frontal lobe

electrode served as reference for both monopolar hippocampi electrodes, and
differential activity between both hippocampi was obtained by a bipolar
connection (Kooi et al., 1978) A frequency range of (0.3-70 Hz) was used at a
sensitivity of 50. All electrodes were grounded from a skull screw. Routinely,
a baseline EEG recording was obtained with artificial CSF infusion (1 pl/min)
for 30 min prior to start of experiments. EEG monitoring were continued
throughout experiments.
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Data analysis
According to a grading scale advanced by Sperk and co-workers (Sperk
et al., 1983), grade I - II seizures are mild limbic seizures manifesting as
immobility, staring, facial grimaces, and occasional episodes of characteristic
torso-and-rear shakes termed wed-dog-shakes (WDS).

Grade III seizures are

moderate seizures characterized by more frequent WDS, automatism
including head-bobbing, forelimb clonus, and some foaming at the mouth.
Grade IV seizures comprise all the above described features of limbic features
and include standing on rear limbs, rearing and eventual loss of balance due
tonic-clonic convulsions.
death of the animal.

Grade V seizures are severe seizures leading to

In this study, grade III - V seizures were considered

overt, behavioral seizures.
Cell death in hippocampus subfields CA1 - 3 and the dentate hilus was
determined by examining high-power fields
microscope.

(3 - 4) under the light

For each animal, average cell death was obtained from 6-10

successive sections through the dorsal hippocampus. In pilot experiments, all
dead/dying cells were clearly identifiable by the silver stain technique and no
correction for cell loss was required.

Also, the silver stain allowed

visualization of both dead/dying neurons as well as background neuronal
architecture, so that counter-staining was not routinely required.

Statistical

significance of the association between treatments (experimental and
controls) and a particular outcome (cell death or seizures) was determined by
the chi-square analysis.

In these calculations, cell death was treated as a

variable.
[3H]-ouabain studies produced film images of exposed sections
(autoradiographs). After development, autoradiographs were analyzed by the
MCID densitometric System (Imaging Research, St. Catharines, Canada).
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Densities were determined as the average of multiple small windows
sampled from 6-10 enlarged images taken randomly from cortical and
hippocampal regions.

Statistical difference between groups was assessed by

chi-square analysis.
All EEG tracings were compared to baseline recording on the basis of
amplitude, frequency and pattern of waveforms.
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RESULTS

The kainate dose-response curve
The dose-response curve for young adult, male, Sprague-Dawley rats
obtained in these experiments is illustrated in Figure 6. Kainate was given in
the range 3-12 mg/kg (i.p.). The dose-response curve was steep, reflecting the
drastically different behavioral responses observed for animals receiving low
doses of kainate compared to animals receiving moderate to high doses.

At

low kainate doses of 3, 5, and 7 mg/kg (i.p.), i.e., kainate doses < 7 mg/kg, only
2 of 19 animals experienced seizures. For a moderate dose of kainate (8 mg/kg
i.p.), 7/8 animals experienced seizures. High-dose kainate (10 and 12 mg/kg;
i.p.) produced severe and prolonged seizures in all animals (n= 6).

Behavioral

observations

The behavioral response to varying doses of kainate has already been
extensively reviewed (Ben-Ari, 1985; Sperk, 1994) and will be presented only
briefly here. Most aninimals (17/19) treated with low-dose kainate exhibited
Sperk grade I - II seizures (Sperk, 1983). In general, animals became restless,
moving incessantly around the cage few minutes after kainate injection.
Between 20 to 30 minutes after kainate injection, animals displayed repetitive
scratching behavior interrupted by episodes of immobility and staring.
Thereafter, between 30 - 40 min after kainate injections, animals exhibited
WDS.

WDS were the most severe behavioral changes observed in most

(17/19) animals receiving < 7 mg/kg (i.p.) of kainate. Typically, these WDS
increased in frequency and abated subsequently within 60 - 90 min.
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Animals treated with moderate or high-dose kainate behaved similarly
to animals treated with low-dose kainate up until onset of WDS. In moderate
and high-dose kainate-treated animals experiencing seizures, WDS increased
in frequency until generalized, clonic-tonic convulsions appeared (Sperk
grade III - IV).

These episodes consisted of up to 3 min of sustained seizure

activity manifested as head bobbing, facial grimaces and foaming from the
mouth.

In severe cases, rearing and eventual standing on rear limbs with

bilateral fore-limb clonus (pedaling) occurred, ending sometimes in loss of
balance and falling. There was a trend to suggest that the seizure severity and
rate of progression to ictal behavior increased with increasing dose of kainate.
In animals receiving moderate dose kainate (8 mg/kg; i.p.; n= 8), the latency
to onset of WDS measured 39+5 min (SEM; measured for 4/8 animals).
Latency to onset of overt seizures was on average 112 +_ 20 min (SEM;
measured for 2/8 animals ) and lasted on average 130 + 12 min (SEM;
measured for 3/4 animals).

At high-dose kainate (10 mg/kg i.p.), WDS

occurred later 57 + 7 min (SEM; n=5), but seizures occurred earlier (91 min + 5
min,

SEM;

animals).

n=5) and lasted longer 300 + 50 min (SEM; measured for 3/5

The mortality rate was 20% (1/5) at kainate concentration of 10

mg/kg, death occurring within the hour (Sperk grade V).

At 12 mg/kg

kainate, the mortality was 100% (1/1).

Histology
Silver staining of brains from all surviving animals (31/33) used for
the

dose-response

curve

revealed

experiencing behavioral seizures.

neuronal

death

only

in

animals

Behavioral changes progressing to and

ending with WDS did not lead to brain damage.

In the brain of animals

experiencing seizures with moderate-dose kainate treatment (7/8), cell death
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was observed in subfields CA2 and CA3, the dentate hilus, and the granule
cell layer.

Pyramidal cells of area CA1 were not routinely damaged by this

dose of kainate. Although not routinely assessed, extra-hippocampal damage
was observed in hippocampal sections containing parts of the thalamus and
amygdala complex.

The pattern of damage in the hippocampus of animals

experiencing seizures with high-dose kainate (10 mg/kg; i.p.; 3/5 animals) was
similar to that of animals treated with moderate-dose kainate.

However, at

high-dose kainate cells in hippocampus area CA1 were routinely damaged.

Partial inhibition of total brain Na±/K±-ATPase Capacity with ICY ouabain
Four animals implanted with cannula as well as intra-hippocampal
EEG electrodes were used for these experiments (Figure 5).

Behavioral

observations

In the first few minutes after beginning ouabain infusion (3 nmoles,
i.c.v. over 9 min), animals generally showed irritability by walking around
the cage in circles.

Five minutes into ouabain infusion, animals became

more restless, and circling behavior was interrupted only by brief periods of
immobility, staring, and occasional WDS.

In subsequent minutes, animals

demonstrated increased overall level of agitation and respiration. At the end
of injections (10 min) animals routinely exhibited vigorous running activity,
lasting on the average ~ 60 sec.

Subsequently, animals showed a variable

period of hypotonia (up to 30 min), sporadic head or body clonus, decreasing
respiratory rates, and eventual return to normal within an hour after
cessation of ouabain infusion.
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EEG Correlates
EEG recordings during ouabain infusion revealed decrease in brain
activity starting by the end of the first minute (Figure 7). Reduced wave
frequency and spike activity compared to baseline was first recorded in the
right hippocampus

(the site of cannula placement)

with

subsequent

progression to the left hemisphere (Figure 7 B & C). Vigorous running at the
end of ouabain infusion was recorded as artifact on the EEG (data not shown).
Reduced brain activity persisted for 30 - 45 min after ouabain infusion,
reverting to baseline patterns thereafter.

No epileptiform discharges were

recorded in any animals (n = 4).

Histology
Silver staining revealed no evidence of brain damage in all four
animals treated with ouabain (3 nmoles; i.c.v) (Figure 8, panel A) or in one
control animal treated with artificial CSF (data not shown).

Results of l3H]Ouabain Binding studies
Densitometric analysis of autoradiographs produced in [3H]-ouabain
binding studies revealed that the number of active pump sites in ouabaintreated animals (n = 3) was approximately twice that of control animals (n = 2)
(Figure 9; p < 0.001, chi-square analysis). The concentrations of [3H]-ouabain
(1 pM) used in this detection method allowed assessement of only highaffinity isoforms (oc2/oc3).

Also, the limited spatial resolution of Ultrafilm

autoradiography allowed assessement of only gross regional variation in
Na+/K+pump density.
control

animals

Thus, in the brain of ouabain-treated animals and in

treated

with

artificial

CSF,

Na+/K+ density in the

hippocampus was twice that of surrounding cortical regions (p < 0.001; chisquare analysis; n = 3 and 2, respectively).
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Partial impairment of total brain Na+/K+-ATPase capacity amplifies kainate
neurotoxicity
From the dose-response curve, a subtoxic dose of kainate (5 mg/kg i.p.)
was determined.

At this dose of kainate, 1/10 animals were observed to

exhibit seizures (Figure 6), and the brain of 9/10 animals not experiencing
seizures revealed no neuronal damage (Figure 8, panel B).

In preliminary

experiments, EEG activity increased above baseline within 10 min after
kainate (5 mg/kg i.p.), suggesting CNS access after IP administration of
kainate within this interval.

Thus, six surgically-prepared animals were

treated with 5 mg/kg (i.p.), followed 1/2 h later by ouabain (3 nmoles; i.c.v.).
Four control animals received ouabain alone 1/2 h after a sham saline IP
injection.

Also, six other control animals received kainate (5 mg/kg; i.p.)

followed by a sham ICV infusion with artificial CSF.
In control animals treated with ouabain alone, no seizure activity was
detected

either

experiments.

behaviorally

or by

EEG,

in

agreement

with

earlier

Also, subsequent histological evaluations revealed no evidence

of brain damage in these animals (Figure 8, panel A).

Similarly, kainate (5

mg/kg, i.c.v.) alone failed to elicit behavioral seizures, epileptiform activity
on EEG, or cell death upon silver staining (Figure 8, panel B).
On the other hand, all 6 animals treated with kainic acid (5 mg/kg; i.p.)
followed by ouabain (3 nmoles, i.c.v.) exhibited behavioral seizures as well as
epileptiform activity on EEG (Figure 10).

Histological examinations of brain

sections from these animals also revealed brain damage in all six animals
(Figure 8, Panels C -F).
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Behavioral

observations

Typically, animals treated with kainate (5 mg/kg i.p.) and ouabain (3
nmoles; i.c.v) became mildly agitated and showed occasional episodes of
immobility and staring after kainate treatment and prior to ouabain
treatment.

Behavioral changes during subsequent ouabain administration

were initially very similar to those observed with ICV ouabain-only
treatments.

Typically,

animals expressed increased levels of restlessness,

scratching, and occasional WDS.

These culminated in vigorous running

activity at the end of injections (9-10 min). WDS appeared on the average 4
min + 2 min (SEM; n= 4) after initiating ouabain infusion. The hypotonia
observed after this running episode in ouabain-only experiments was not
routinely observed in these animals.

WDS returned promptly after the

episode of running and progressed in frequency, culminating in overt seizure
episodes. The average latency to onset of the first seizure episode was 116 + 13
min after ouabain injection (SEM; n= 4). These convulsions were similar to
those of high kainic acid treatment alone, were not associated with obvious
apneic spells, and continued sporadically for 345 + 9 min (SEM; n = 4). In
spite of the severity of seizures occurring after ouabain and kainate, no
animal mortality was observed.
EEG Correlates
EEG recordings were obtained with four animals treated with kainate (5
mg/kg i.p.) followed by ouabain (3 nmoles, i.c.v.) (Figure 10). After kainate
injections and prior to ouabain treatment, an increase in the frequency and
amplitude of brain waves above baseline was observed (Figure 10, panels A,
B, C & D). The increase in brain activity correlated with increased restlessness
during this period.

Upon ouabain administration, characteristic ouabain
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suppression of brain activity was observed beginning within the first minute
(Figure 10, panel E). Attenuated brain waveforms were first observed in the
right hemisphere (cannula site) and then in the left hemisphere 5-10 seconds
later.

However, unlike ouabain-only experiments, brain activity returned

promptly (Figure 10, panel F). After the vigorous running activity observed
at 9 - 10 min, the first set of epileptiform discharges occurred with an average
latency of 17.5 + 2.5 min after the start of ouabain infusion (SEM; n = 4).
Again, seizure activity was first observed in the right hemisphere (site of
ouabain infusion) before appearing in the left hemisphere, separated by 2 - 5
seconds.

Subsequently, a variable period of 15 - 60 min intervened during

which epileptiform discharges were observed on EEG in the absence of any
overt behavioral manifestations of seizure activity. Some of these discharges
corresponded with immobility and staring or facial grimaces.

In general,

these discharges became more frequent just prior to the first observed
behavioral seizure.

Epileptiform discharges were subsequently recorded on

EEG beginning on the average 116 + 13 min (SEM; n=4), and sporadically for
the 6 h for which animals were routinely monitored.
Histology
Analysis of the hippocampus of animals treated with kainate (5 mg/kg;
i.p.) and ouabain (3 nmoles; i.c.v.) revealed widespread damage to
hippocampal neurons.

Neurons of the dorsal hippocampus were heavily

injured, particularly neurons in CA1 and CA3 subfields (Figure 8, panel C.).
Hilar interneurons were consistently damaged (Figure 8, panels C & D).
Damage was not routinely observed in extra-hippocampal regions. Cell death
was observed in the amygdala, but virtually no cell death was observed in the
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thalamus, neocortex, or frontal lobe (data not shown).

Cell death was also

observed in hippocampal area CA2 and in the granule cell layer (Figure 8 C).
Statistical analysis revealed that pairing of ouabain and kainate reliably
produced seizures and neuronal degeneration (6/6 animals; p < 0.001; chisquare analysis). In contrast, kainate or ouabain alone did not (0 of 6 and 0 of
4 animals, respectively; Figure 11).

Onset and severity of seizures depend upon time of ouabain administration
In 8 animals, ouabain was delayed by 90 min after kainate
administrations. Of these, 3 animals were monitored by EEG. All 8 animals
experienced seizures, albeit at different latencies compared to animals treated
with ouabain 30 min after kainate injection. Latency of onset of seizures was
recorded for 5/8 animals and was observed on average to be 282 + 30 min
(SEM) after kainate treatment. This reflected an increase in latency of seizure
onset after kainate treatment of ~70 + 15 min (SEM), compared to animals
treated at 30 min interval.

However, latency of seizure onset from ouabain

injection did not differ significantly for both groups (Figure 12). The duration
of overt, successive seizure episodes also shortened notably (~ 150 min) as
determined for 6/8 animals. Notable differences between EEG recorded for
animals treated with ouabain at 90 min versus 30 min after kainate injection
included: i) an almost complete return to baseline of brain activity 60 - 80 min
after kainate injection and prior to ouabain infusion, and ii) a reduction in
the number of, and duration in which, epileptiform discharges occurred.
When ouabain was administered at 90 min, the first epileptic discharge
appeared on EEG 22 + 4 min (SEM; n = 3) after ouabain injection and was not
significantly different in latency of onset compared to animals administered
ouabain 30 min after kainate. Histological study of neuronal death in these
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animals revealed a pattern of brain damage similar to those described above
for animals receiving kainate and ouabain at 30 min interval.

Intraperitoneal injections of both ouabain and kainate replicate results of
experiments with kainate (i.p.) and ouabain (i.c.v)
In preliminary studies, ouabain (1 mg/kg; i.p.) in combination with
kainate (5 mg/kg; i.p.) failed to elicit any observable seizure activity (data not
shown).

Subsequently, an experimental group was treated with ouabain (1

mg/kg; i.p.) followed by kainate (7 mg/kg; i.p.; 8 animals). Kainate control
animals received saline followed by kainate (7 mg/kg; i.p.; n = 8).
ouabain control animals received
saline (i.p.).

Four

ouabain (1 mg/kg; i.p.) followed with

Animals were then observed for behavioral manifestations of

seizures for up to 8 hrs after kainate injection.
Table 1 (next page) illustrates results from this experiment.

Within 5

min of injections, all 4 control animals treated with ouabain (1 mg/kg; i.p.)
demonstrated mild agitation and increased respiration rate with return to
normal within 1 hr. Seizures or hippocampal cell death were not observed in
these animals. Seizures were observed in only 1 of 8 control animals treated
with kainate (7 mg/kg; i.p.). The rest of kainate control animals not seizing
(7/8) typically experienced WDS which appeared between 20 - 40 minutes after
kainate injections and tapered off within an hour of onset.

Six of eight

animals receiving ouabain (1 mg/kg; i.p.) followed by kainate (7 mg/kg; i.p.)
experienced overt limbic type seizures.
Histological studies of neurodegeneration revealed no brain damage in
all control animals, except in the one control animal that experienced
seizures with 7 mg/kg (i.p.) kainate. Silver staining of animals experiencing
seizures from treatments with ouabain followed by kainate (7 mg/kg; i.p.)
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TABLE 1

CONTROLS
Ouabain (1 mg/kg; i.p.)

kainate (7 mg/kg; i.p.)

Seizures

Neuronal
Death

—

—

—

4

1

1

—

8

6

6

Mortality

TOTAL

EXPERIMENTAL
Ouabain (1 mg/kg; i.p.)
+
kainate (7mg/kg; i.p.)

8
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revealed neuronal injury in the hippocampus similar to that already
described for animals treated with ouabain (i.c.v.) and kainate (i.p.) (Figure
13A & B).
Statistical analysis of these results showed that pairing of ouabain and
kainate reliably produced seizures and neuronal degeneration (6/8; p < 0.001;
chi-square analysis), compared to control animals treated with ouabain (0/6)
and kainate (1/8).
Pattern of hippocampal damage and chronic features of kainate and ouabain
treated animals
i) Pattern of hippocampal cell death
The pattern of hippocampal cell damage observed for animals treated
with kainate and either ouabain (i.c.v) or ouabain (i.p.) were essentially the
same. All hippocampal cells were affected, including cells in subfields CA1 CA3.

Cell death was observed in the dentate hilus and in the granule cell

layer.

Granule and CA2 pyramidal cells were relatively spared (Figures 8,

panels C, D, E, &F and Figure 13).
ii) Spontaneous, recurrent seizures
Three animals treated with ouabain (1 mg/kg; i.p.) followed by kainate
(7 mg/kg; i.p.) were allowed to recover and observed for spontaneous
behavioral manifestations of seizures.

Two animals were observed for 30

days and one for 90 days. Handling elicited spontaneous limbic type seizures
in all three animals, beginning day 14, 15, and 30, respectively. These episodes
were characterized by head clonus, facial grimaces and automatism. No overt
tonic-clonic seizures were observed.

In a control animal treated with sham

surgery, no spontaneous recurrent seizures were observed.
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iii) Hippocampal remodeling
At 30 and 90 days after experiments, animals observed for spontaneous
recurrent seizures were sacrificed and their brains were examined for
evidence of hippocampal remodeling by Timm stain.
Examination of the dorsal hippocampus of an animal that seized
from treatment with ouabain (1 mg/kg; i.p.) and kainate (7 mg/kg; i.p.)
showed sprouting of granule cells into the inner molecular layer (Figure 14
B). Also notable was a thinning of the heavily stained outer molecular layer
of area CA1 compared to control (Figure 14B; arrow heads). Timm staining of
brain sections from control animals three months after the experiment
showed no remodeling of the hippocampus (Figure 14A).
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FIGURE 6: The kainate dose-response curve

This graph illustrates the percentage of animals exhibiting overt behavioral
seizures. (Numbers of animals at the dose are over black dots).
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Figure 7

1 second
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Figure 7: Electroencephalographic recording during ouabain (3 nmoles; i.c.v).
Panel A shows typical, baseline, resting activity prior to injection.
Panel B shows hippocampal activity 2 min after start of ouabain
infusion.

There

is

decreased

EEG

amplitude

in

the

right

hippocampus (RH) - the hemisphere containing the infusion port with persistent baseline activity in the left hippocampus (LH). The
effects of ouabain are seen ~ 5 min later in the left hippocampus
with persistent suppression of activity in the RH (Panel C).

(RH -

LH: potential difference between RH and LH in reference to frontal
lobe electrode).
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Figure 8

' V
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Figure 8: Neuronal death in the dorsal hippocampus associated with various
treatments.
Ouabain (3nmoles; i.c.v.), although producing an extreme pattern of
motor behavior did not produce neuronal death (panel A).

Non¬

seizure producing dosages of kainate (e.g. 5 mg/kg; panel B) do not
cause neuronal death as assessed by silver degeneration stain which
shows dead/dying cells and their processes as black (arrow in panel
B seperates CA2 and CA1 regions). Pairing of ouabain and kainate
produced widespread death throughout the hilus (Hi) and
CA1/CA3 subfields (panel C). Note fiber staining of apical dendrites
of pyramidal cells in stratum
arrows).

radiatum (SR) in panel C (small

Similar to human TLE, pyramidal neurons of the CA2

subfield were predominantly spared. A variety of hilar neurons are
affected (Panel D: Higher magnification and orientation reversed)
including those of the mossy cell morphology.

Panels E and F

correspond to high power views of degenerating CA3 and CA1
pyramidal neurons. ( ML : molecular layer of the dentate gyrus; GC:
granule cell layer; SO, SP, and SR: stratum oriens, pyramidale, and
radiatum , respectively).
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Figure 9

A

B
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Figure 9: [3H]Ouabain Binding Studies
A. CSF controls
B. Ouabain-treated aninals.
Autoradiography to assess Na+/K+pump density was achieved by
pre-incubating sections to allow bound ouabain (administered in
vivo) to dissociate and then incubating with [3H]-ouabain
equilibrium.

to

Densitometric analysis revealed that on average,

binding density approximately doubled with ouabain pre-treatment
compared to controls (p < 0.001; chi-square analysis; n = 3).
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Figure 10
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Figure 10: Representative electroencephalographic recording of ouabain and
kainate-treated animal.
A. Shows typical, baseline resting activity prior to drug injection.
B.

Shows hippocampal activity 10 min after a subtoxic dose of

kainate (5 mg/kg; i.p.) was injection (note prominent spikes). Later
recordings, panels (C & D), show progression of activity back
towards baseline. Panel E shows ouabain (3 nmoles) injection into
the

right

ventricle;

hippocampal activity.

note

drastic

suppression

of

bilateral

Activity resumes promptly, displaying

progressively higher frequencies and amplitude (panels F, G). Panel
H and I shows two patterns of EEG activity during seizures. (RH:
right hippocampus; LH: left hippocampus).
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Figure 11
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Figure 11: Ouabain potentiates sub-toxic kainic acid.
This figure shows results of experiments to test the hypothesis that
partial inhibiton of Na+/K+ pump capacity with ouabain increases
kainate neurotoxicity. 1) Four control animals were treated with
ouabain alone and none of these animals (0%) experienced seizures
or neuronal death. 2) Six control animals were treated with kainic
acid alone and no animals (0%) experienced seizures or neuronal
death. 3) Six animals were treated with a combination of ouabain
and kainate and all six (100%) experienced seizures and neuronal
death. (Number of animals and percentage of positive outcomes
appear in boxes below questions investigated; KA: Kainic acid).
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Figure 12
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Figure 12: A delay in ouabain administration increases the latency of seizure
onset after low-dose kainate but shortens seizure duration.
When subtoxic dosages of kainate (5mg/kg; i.p) were followed 30
min later by ouabain (3 nmoles; i.c.v.), severe seizures routinely
developed with an average latency of 116 + 13 min (SEM) hrs after
kainate. These convulsions continued for a duration of 345 + 9 min
(SEM).

Delaying ouabain administration by 90 min increased the

latency of the onset of seizures (by 70 + 15 min), and the duration of
epileptic discharges under this paradigm shortened notably (-150
min). (KA: Kainic acid).
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Figure 13
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Figure 13: Silver stain of hippocampus of animal treated with ouabain
(1 mg/kg; i.p.) and kainate (7 mg/kg; i.p).
A. Pyramidal cells of areas CA3 and area CA1 are heavily damaged
(dark silver granules). Neuronal death is also present in the hilus
(Hi). Cells of the granule cell layer (GC) and area CA2 (not shown)
are relatively spared.
B. Higher magnification of hilus in A, showing "selective" hilar
damage.
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Figure 14
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Figure 14: Timm stain of rat hippocampus
A. Control
B. 30 days after treatment with kainate (7mg/kg; i.p.) and ouabain (1
mg/kg; i.p).

Sprouting of mossy fibers into the inner molecular

layer of the dentate girus is present (large arrows).

A prominent

loss of staining is observed in area CA1 (small arrows), reflecting
significant damage to cells in this area by initial treatment with
kainate/ouabain.
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DISCUSSION

THE KAINATE DOSE RESPONSE CURVE

As previously stated, the response to kainate in many animals
including rats is not only dose dependent, but it is also influenced by age, sex,
route of administration, and strain variations in the same species of animal
(Sperk, 1994). Steep dose-response curves similar to the one observed in this
study have previously been reported, albeit under different conditions.
Lothman and co-workers (Lothman and Collins, 1981) administered
increasing amounts of kainate (0.3 - 12 mg/kg) intravenously to albino rats
weighing 280 - 350 g and identified three dose ranges: with a low dose range
(0.3 and 1 mg/kg) animals exhibited staring only, without signs of seizure
activity; animals treated with an intermediate dose of kainate (4 mg/kg)
exhibited staring, WDS, automatisms and mild limbic convulsions, but never
experienced severe limbic convulsions; and animals treated with high-dose
kainate exhibited a range of seizure manifestations including severe limbic
convulsions.
The characteristic steepness of the dose-response curve observed may
be partly explained by changes in BBB permeability after systemically
administered kainic acid. Kainate penetrates the BBB poorly. Less than one
percent of the systemically injected kainic acid reach the brain (Berger et al.,
1986).

Access to the brain after systemic administration is also gradual,

reaching plateau levels in perfused brain of 10-day old Winstar rats in
approximately the same time as the onset of seizures (~ 20 min).

Studies
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have shown that this kinetics of CNS penetration is partly dependent on BBB
disruption by increasing doses of kainic acid reaching the brain (Saija et al.,
1992). Thus, at sufficient doses of kainate, CNS penetration by the neurotoxin
become synergistic, gradually enhanced by disruption of BBB, leading to the
sigmoid shape of the dose response curve observed (Figure 6).

OUABAIN INDUCES 2-FOLD INCREASE IN NA+/K +PUMP DENSITY

In this study, the concentrations of ouabain used allowed inhibition of
the high-affinity (a2/a3) Na+/K+ pump isoforms.

This preferential

inhibition, as already explained, establishes partial impairment of total
Na+/K+ pump capacity (Brines and Robbins, 1992). Total inhibition of brain
Na + /K+ pump would kill animals, since neurons require some Na+/K+
pump for cellular integrity (Garthwaite et al., 1986; Lees et al., 1990).
In assessing Na+/K+ pump density in ouabain-treated animals,
conditions of incubation were selected to activate the Na+/K+ pump
uniformly by providing the required cations and sufficient ATP (Caspers et
al., 1987; Brines et al., 1995). The paradoxical increase in the Na+/K+ pump
density in ouabain-pretreated animals is most likely in response to
impairment with ouabain.

It is likely that complete inhibition of the high

affinity (a2/a3) isoforms induced a near total replacement of these pump
units. Consequently, a doubling in the population of high-affinity isoforms,
was detected. Although the exact mechanisms of upregulation are not clear
(via production of new protein or cell surface translocation from inactive
pools) this type of recruitment of additional pump units may result in a net
reduction of the total (active + dormant) Na+/K+ pump capacity. However
Na+/K+pump inhibition could not be quantitated by the technique used here.
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OUABAIN POTENTIATES KAINATE NEUROTOXICITY

Our experimental results demonstrated that partial inhibition

of

Na + /K+ pump capacity decreases neuronal ability to survive otherwise
innocuous excitatory stimuli.

All experimental animals treated with kainate

(5 mg/kg; i.c.v.) followed with ouabain (3 nmoles; i.c.v.) experienced seizures
and subsequent brain damage, however no control animals experienced
seizures or neuronal injury.

Further experimental evidence suggested that

neurotoxicity due to kainate (5 mg/kg; i.p.) was intimately associated with
Na+/K+ pump inhibition. Thus time of seizure onset after kainate treatment
was dependent on time of ouabain administration (Figure 12). The shortened
duration of epileptiform activity observed when ouabain is administered at
90 min, instead of 30 min after kainate, could be explained by decreasing brain
levels of kainate with time.

Such that, when ouabain is administered at 90

min, lower brain levels of kainate are present.

Indeed, the behavioral

manifestations as well as neurotoxicity of systemically administered kainate is
dose-dependent (Sperk et al., 1983; Ben-Ari, 1985), as supported by our doseresponse curve.

These findings were replicated by intraperitoneal injections

of both kainate and ouabain.

Thus, experimental groups treated with a

combination of kainate and ouabain were significantly different from
controls, producing seizures and subsequent neuronal death (p< 0.001; chisquare analysis).
EEG recording after administration of kainate (5 mg/kg i.p.) revealed
increased neuronal activity above baseline.

This can be explained by the

excitatory action of kainate, since neuronal exposure to low levels of
glutamate

or

its

analogs

(including

kainate)

leads

to

depolarization, influx of Na+ and efflux of K+ (Rothman, 1985).

immediate
Under these

conditions, the Na+/K+ pump is secondarily activated to rectify the resultant
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ionic disturbance (Rossier et al., 1987; Skou, 1988).

Indeed, increased

metabolic activity correlating with systemic treatment with kainate has been
observed with 2-deoxyglucose uptake studies.

Thus, when male Wistar rats

were treated with kainate (i.v.), increased glucose uptake was detected in the
brain, albeit only in the hippocampus and lateral septum at low-dose kainate
(6 mg/kg).

At higher doses (12 mg/kg), increased metabolic activity was

detected in other brain regions as well (Saija et al., 1992).

However, as

evidenced by the absence of brain damage in control animals, homeostatic
mechanisms, most likely dependent on Na+/K+ pump activity, prevented
neuronal injury from sub-toxic kainate (5 mg/kg; i.p.).
The scenario, however, changes with injection of ouabain (3nmoles;
i.c.v.) 30 min after kainate (5 mg/kg; i.p.) treatment.

Impairment of Na+/K+

-ATPase in these circumstances may interfere with neuronal mechanisms to
cope with an otherwise innocuous brain level of kainate.

Precedence for this

concept exists in vitro. Stimulation of CA1 pyramidal cells with impairment
of Na+/K+pump activity markedly reduced the capacity of these cells to
restore transmembrane gradients (Novell! et al., 1988).

Also, inhibition of

Na + /K+ -ATPase function in these neurons markedly potentiated and
prolonged glutamate depolarization (Thompson and Prince, 1986; Fukuda
and Prince, 1992).

MECHANISMS BY WHICH OUABAIN MAY POTENTIATE KAINATE

There are several potential mechanisms by which ouabain may
potentiate kainate neurotoxicity.

Increased endogenous levels of glutamate or its agonists
In addition to an already higher than normal brain level of kainate
imposed by our experimental design, endogenous extracellular levels of
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glutamate may rise due to Na+/K+ pump inhibition.

Sampling of rat brain

extracellular milieu by microdialysis after Na+/K+ pump inhibition with
ouabain have shown 2-3 fold increase in the release of glutamate (Jacobson et
al., 1986; Westerink et al., 1989).

Furthermore, inhibition of Na+/K+ ATPase

may lead to a block of glutamate re-uptake mechanisms, causing an increase
in intracellular levels of endogenous glutamate (Kanner and Sharon, 1978;
Dagani and Erecinska, 1987).

Since the Na+/K+ pump is required for

repolarizing the cell membrane after depolarization, chronic neuronal
depolarization

(by

glutamate

and

kainate)

in

the

face

of

reduced

Na+/K+pump capacity may lead to inadequate neuronal repolarization (Skou,
1988).

This situation would lead to increased excitability of the neuron and

subsequent seizure generation.

Release of other potentiating compounds
Infusion of ouabain into rat striatum has been demonstrated to
produce a massive release of dopamine (Westerink et al., 1989; Fairbrother et
al., 1990).

On the other hand, since dopamine may inhibit Na+/K+-ATPase

(Bertorello et al., 1990), a vicious cycle may be created to perpetuate a spiral
decrease in Na+/K+ ATPase activity. Other compounds released after Na+/K+
pump release include gamma-amino butyric acid (GABA) and acetylcholine
(O'Fallon et al., 1981; Jacobson et al., 1986; Westerink et al., 1989).

Indeed,

GABA has been shown to accelerate cortical neuronal death in vitro (Erdo et
al.,

1991).

Also,

acetylcholine

can

potentiate

glutamate

hippocampal cell cultures in vitro (Mattson et al., 1989).

toxicity

of

I
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Limited Na+/K+ pump reserve capacity
The paradoxic doubling of Na+/K+ pump binding sites in the brain of
animals treated with ouabain (i.c.v.) as observed by tritiated ouabain studies
has already been discussed. Although the concept of neuronal recruitment of
Na+/K+ ATPase reserve-capacity to meet increasing demand is not clearly
understood, it is likely that the cell is unable to recruit reserve pump units

fast enough to prevent irreversible injury.

Conversely, a scenario may be

engendered in which all recruited pumps (whether by translocation to the cell
surface from existing stores or by de novo synthesis) are readily inhibited by
ambient ouabain.

Since ouabain was used in the micromolar range, the high

affinity oc2/a3 isoform may be chronically inhibited, and al isoforms may in
fact become the only recruitable Na+/K+ pump pool.

Indeed it has been

suggested that the significance of differential affinities and Km's observed for
rodent Na+/K+ pump isoforms may be a teleological one: to allow the neuron
to establish reserve Na+/K+ pump capacity for recruitment as needed
(McGrail et al., 1991; Brines and Robbins, 1993). In any case, with unmatched
demand for pump activity, the stage may be created for irreversible events of
excitotoxicity (Choi, 1992).

Synergistic disturbance in the neuronal ionic milieu
As already introduced, neuronal exposure to EAA leads to disturbance
in ionic balance resulting primarily from Na+ and Ca++ influx and K+ efflux.
Extensive evidence has shown that the ionic changes in Na+, K+, and Ca++
occurring with direct or indirect inhibition of the Na+/K+ pump (Baker et al.,
1969; Goddard and Robinson, 1976; Reeves and Sutko, 1979; Ullrich et al.,
1982) are exactly those observed by excitotoxicity, albeit by different
mechanisms (Choi, 1988; Kohr and Heinemann, 1988; Stable et al., 1990).
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Consequently, ouabain may potentiate kainate neurotoxicity by a synergistic
ionic disturbance.

Excitotoxicity as a final common pathway
Any of the above described mechanisms may eventually lead to a net
increase in intracellular Na+ due to compromised or insufficient pump
activity.
result.

Water may follow passively into the cell and cell swelling may

This would mark the first phase of excitotoxicity.

Subsequently, the

second phase of excitotoxicity may ensue if pump capacity is continuously
impaired.

This would be marked by Ca++ influx and inevitable neuronal

injury. (Choi, 1992).

Neuronal injury resulting from Na+/K +

inhibition during excitatory stimulation has

pump

been previously observed in

vitro by Brines and co-workers. Up to a 6-fold increase in neuronal injury (as
assessed by lactic dehydrogenase release) was observed when ouabain treated
cultures were stimulated with glutamate (Brines and Robbins, 1992).

As

suggested by Choi, "[neuronal] insults are likely to induce cell death by several
simultaneous injury processes (Choi, 1992)."

Occasionally, some of these

processes may act synergistically to induce cell death when the summation of
their individual effects overwhelms the cell's primary ionic homeostatic
mechanism, the Na+/K+ pump.

Evidence from human epileptic hippocampi
Results of studies from surgical specimen of epileptic hippocampi
provide some impetus for the hypothesis tested here.

Mapping of Na+/K+

pump density per unit of protein for various regions of epileptic and non¬
epileptic hippocampi revealed that hippocampal areas usually destroyed in
epilepsy (e.g. area CA1) possessed the lowest total density of Na+/K +pump
units, whereas those more resistant areas (area CA2, the dentate molecular
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layer, and the subiculum) possessed the highest Na+/K+ pump density
(Brines et al., 1995). In this same study, activity of cytochrome c oxidase, the
enzyme producing ATP required for Na+/K+ pump function was generally
reduced in epileptic hippocampi compared to hippocampi from autopsy
controls.

Consequently, although pump density was determined to be

increased in vulnerable areas of the brain in epileptic patients, the capacity to
power them was reduced.

These findings suggested two things: 1) in the

epileptic hippocampi, cells expressing lower densities of Na+/K+ pump are
more susceptible to excitotoxicity as may occurs in seizures and 2) a defect in
energy production may be part of the pathoetiology of epilepsy.

NEUROPATHOLOGY

The pattern of cell death observed after kainate/ouabain treatments,
like that observed with high-dose kainate, is one of selective cell damage.

A

notable difference, however, include death to pyramidal cells in area CA1
with kainate/ouabain treatments.

These cells express only low levels of

kainate receptors (Monaghan and Cotman, 1982) and this may explain their
lower vulnerability to kainate-only treatment.

However, like other cells in

the hippocampus, CA1 cells express high levels of glutamate receptors (Sperk,
1994).

Consequently, increase in endogenous glutamate levels either from

inhibition of re-uptake mechanism (Kanner and Sharon, 1978; Dagani and
Erecinska, 1987) or by neuronal depolarization (Jacobson et al., 1986;
Westerink et al., 1989) may lead to excitotoxicity of CA1 cells.

Conversely,

these cells may have been damaged by hypoxia, since they are exquisitely
sensitive to this insult (Wasterlain et al., 1993).

Although arterial oxygen

saturation were not measured during seizures, apneic episodes were not
observed to suggest cell death by hypoxia.
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On the other hand, the destruction of pyramidal cells of hippocampus
area CA3 observed with the combination of kainate and ouabain have been
observed in several other situations.

These cells are vulnerable to several

treatment including kainate alone (Ben-Ari et al., 1981), ischemia (Johansen
et al., 1987), and electrical stimulation of the perforant pathway into the
hippocampus (Sloviter, 1987).

The exceptional vulnerability of these cells

may be explained by one or a combination of several factors.

Cells in area

CA3 express the highest density of kainate receptors in the hippocampus
(Monaghan and Cotman, 1982; Berger and Ben-Ari, 1983; de Lanerolle et al.,
1992) making them more vulnerable to direct kainate excitation.

Secondly,

area CA3 is the region of the termination of a major excitatory pathway to the
hippocampus, the perforant pathway (Figure 1). Consequently, these neurons
may be chronically stimulated during seizures. Thirdly, the hippocampus, the
olfactory cortex, the retina, and cerebellum are among some of brain regions
expressing the highest level of Na+/K+ATPase. Consequently, Na+/K+ pump
inhibition may be particularly severe in the hippocampus making these cells
more vulnerable.

It is unlikely that ouabain acts by other mechanisms such

as modification of cerebrospinal fluid to produce neuronal injury, since the
choroid plexus appears to express only the al (low affinity) isoform (Brines et
al., 1991).
Although it is believed that impairment of Na+/K+ pump capacity led
first to seizure generation and subsequently to neuronal injury, the possibility
that seizure activity itself contributes
kainate/ouabain

treated

animals

to

cannot

the pathology observed in
be

ruled-out.

Parenteral

administrations of kainic acid may not allow toxic levels of kainic acid to be
reached in the vicinity of all neurons. Initiation of seizure activity in areas of
low seizure threshold such as area CA3 may exert strong excitatory actions
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upon certain neuronal pathways (Figure 1), which in turn may cause seizures
and distant, albeit excitotoxic, brain damage in certain target neurons.

The

most direct support for this mechanism comes from the work of Sloviter and
co-workers.

These investigators demonstrated that sustained stimulation of

the perforant path (Figure 1) in the rat results in similar damage of CA3 and
hilar neurons of the hippocampus as observed in kainic acid induced seizures
(Sloviter, 1983). Further support for this mechanism stems from the effect of
anticonvulsants on kainate-induced neurotoxicity.

The mode of action of

these drugs is such that they do not interfere with kainate binding to
neuronal cells (hence the direct interaction of kainate with neuronal cells
persists), instead their neuroprotective action is achieved by increasing the
seizure threshold (Bernard et al., 1980; Frandsen et al., 1990; Stone and Javid,
1980).

Thus, these agents reduce neurotoxicity by mitigating a contribution

from seizure activity. In this respect, seizure activity itself, by establishing a
chronic, recurrent neuronal excitation may contribute to neuronal cell death.
A second seizure-related mechanism of kainate neurotoxicity suggests
that brain damage may be related to hypoxia, hypoglycemia or edema. Kainic
acid induced damage to the frontobasal as well as the temporobasal portions
of the brain have been attributed to this mechanism.

A characteristic

incomplete parenchymal necrosis is observed in these areas (Spielmeyer,
1927; Levine, 1960), although the pattern of cell death is still quite different
from that observed by hypoxia or ischemia alone (Sperk et al., 1983). It has
also been suggested that the early edema resulting from severe seizures may
compromise venous drainage and blood supply to affected brain areas
(Spielmeyer, 1927; Lassmann et al., 1984; Lassmann, 1984; Sperk et al., 1983).
This mechanism may play a role in damage to extra-hippocampal brain areas;
however, there is less support for its role in the damage to Ammon's horn
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during seizures. Since, substantial decrease (35%) in partial oxygen pressures
in the hippocampus during the initial phases of seizure activity is
compensated for by at least a 3-fold increase in local blood flow in this region
(Pinard et al., 1984).

74
TEMPORAL LOBE EPILEPSY AND ANIMAL MODELS

The human pathology
In the period since Sommer's qualitative description of Ammon's
horn sclerosis (Sommer, 1880), several more elaborate and quantitative
descriptions of the neuropathology of TLE have been presented (Margerison
and Corsellis, 1966; Corsellis and Bruton, 1983; Babb et ah, 1984; Gloor, 1991;
de Lanerolle et ah, 1992 and 1994; Kim et ah, 1990). The present consensus is
that neuropathology of human TLE is mostly confined to the hippocampus
and involves other brain regions only minimally.

Also, a highly variable

pattern of cell loss has been described (de Lanerolle et ah, 1994). Cell loss may
be minimal, involving only hilar interneurons (Margerison and Corsellis,
1966) or it may be pervasive throughout Ammon's horn with substantial
(>50%) loss of CA1 - CA4 pyramidal cells and dentate granule cells (Babb et ah,
1984; Kim et ah, 1990). Granule cells and CA2 pyramidal cells are generally
less vulnerable, although all neuronal populations can be affected.
Furthermore, damage to cells of the dentate gyrus is selective, with
preferential

loss

of

interneurons

expressing

somatostatin

(SOM),

neuropeptide Y (NPY) and substance P (SP) (de Lanerolle et ah, 1989). In fact,
the selective loss of these interneurons is a reliable diagnostic feature of
mesial TLE patient (de Lanerolle et ah, 1994). Another histological feature of
epileptic hippocampi is neuronal plasticity and remodeling.

Sprouting

describes a process of axonal growth and establishment of new fibre systems
in the epileptic hippocampi. Although several types of sprouting have been
observed, mossy fiber sprouting into the dentate inner molecular layer has
been more extensively studied.

The functional consequence(s) of sprouting

remains to be established, although it is thought that sprouting may
participate in the pathology of human TLE (Sloviter, 1992).
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Animal

models

There has been considerable effort to create an experimental animal
model to study the etiology of seizures and neuronal damage in human TLE.
To bear some relevance to the human disease, a useful animal model must
fulfill the following criteria at least: (a) the focus of seizure generation must
be in the hippocampus; (b) it must be chronic, reproducing spontaneously and
repetitively; (c) the pathology must resemble that observed in the human
disease, showing damage to pyramidal cells, granule cells, and hilar
interneurons as described above; (d) damage to hilar interneurons must be
selective for NPY, SP, and SOM expressing neurons; and (e) it must show
evidence of hippocampal plasticity (sprouting).
The kainate, rat model
Kainic acid has been administered intraperitoneally (Ben-Ari et al.,
1981), intravenously (Lothman and Collins, 1981) intraventricularly (Nadler
et al., 1987), and directly into the hippocampus (Ben-Ari et al., 1979; Schwob et
al., 1980).

Limbic structures, primarily the hippocampus, are the focus of

seizure activity for kainate treated animals exhibiting seizure activity (Sperk,
1994).

Spontaneous seizure recurrence has been observed with this model

(Pisa et al., 1980; Cronin and Dudek, 1988). Kainate-lesioned hippocampi also
show long term remodeling (Tauck and Nadler, 1985; Cronin and Dudek,
1988). However, as already introduced, there are several differences between
this model and the human pathology.

To adequately replicate the human

pathology, high doses of kainate are used.

This not only leads to a high

animal mortality (Ben-Ari et al., 1981, Lothman and Collins, 1981; Sperk,
1994), but also it leads to widespread, extra-hippocampal brain damage not
commonly observed in the human pathology (Ben-Ari et al., 1981).
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Moreover, cells of area CA1 which are destroyed in the human disease are not
routinely damaged in the kainate rat model.

From the data available, it

appears that the kainate rat model does not replicate the selective hilar cell
loss observed in the human disease. In contrast to the human situation, hilar
SOM mRNA content was observed to decrease between 10 - 30 days after
kainate treatment, where as NPY mRNA increased and SP content remained
unchanged (Sperk, 1994).
The pilocarpine model

This model uses intraperitoneal injections of pilocarpine to induce
severe motor limbic seizures and status epilepticus in rats (Turski et al., 1983;
Turski et ah, 1989). Following the acute seizure episode, the animals show
relatively normal behavior for several weeks, and then a high percentage
develop spontaneous recurrent seizures (Leite et ah, 1990; Cavalheiro et ah,
1991). Evidence for substantial mossy fiber recurrent sprouting has also been
shown to occur in the hippocampus of these animals (Mello et ah, 1990).
However, the pathology described for this model considerably falls short of
the human scenario. Widespread, extra-limbic damage not observed in the
human pathology, including damage to the mediodorsal thalamic nuclei,
substantia nigra and neocortex is commonly observed (ibid). Damage of CA3
and CA1 neurons is achieved at high levels of pilocarpine, resulting in high
animal mortality (Turski et ah, 1986). Although, the pattern of hilar cell loss is
not completely characterized in this model, preliminary studies suggest a loss
of GABAergic interneurons (Obenaus et ah, 1993). This is in sharp contrast to
the human pathology in which GABAergic interneurons are quite resistant to
injury (Babb et ah, 1989). The status of SP, NPY, and SOM containing hilar
interneurons remains to be established for this model.
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The afferent excitation model
Sloviter and coworkers

(Sloviter, 1983; Sloviter, 1987) advanced the

afferent excitation model produced by 8 - 24 hrs of intermittent stimulation of
the perforant pathway in anesthetized rats.

This method reliably results in

selective damage of specific neurons in the dentate hilus, including SOM and
NPY containing interneurons (Sloviter, 1991). Damage to pyramidal cells by
this technique is more variable.

Prolonged stimulation (>12 hrs) results in

selective, but often inconsistent, damage to neurons of hippocampus area
CA3 and CA1; however, as in the human pathology, pyramidal cells of area
CA2 and granule cells are relatively undamaged (ibid).

An increased

excitability of granule and CA1 pyramidal cells is observed in this model after
the

period

of

intermittent

stimulation.

Although

this

represents

'hippocampal remodeling' it is dissimilar to 'sprouting' as it does not
involve the growth of new fiber systems.

Moreover, convulsions and

chronic, recurrent seizures do not occur with this model (Sloviter, 1987).
Consequently, the afferent excitation model not only fails to adequately
replicate the human pathology, but it also fails to reproduce the seizure
syndrome observed in the human disease.
The kainate/ischemia rat model
More recently, intraventricular kainate and ischemia have been
combined to produce a 'mesial temporal sclerosis' in rats (Franck and Roberts,
1990).

The pattern of brain damage observed here is a combination of

ischemia-induced and kainate-induced damage.

Reportedly, there is a

selective loss of dentate hilar neurons and CA3/CA1 pyramidal cells of the
ventral hippocampus.

Like the damage observed in the human disease,

dentate granule cells and an intermediate portion of the pyramidal cell layer
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(presumably area CA2) are spared. This model suggests that the pathology
observed in human TLE is partly a result of ischemia.

Many authors,

however, do not believe that the damage to hippocampal pyramidal cells is
due to seizure-related ischemia.

As discussed previously, direct evidence

suggests that there is no mismatch between blood supply to, and metabolic
activity in, Ammon's horn during seizure activity (Meldrum, 1983; Auer and
Siesjo, 1988). This model remains to be adequately characterized.

A seizure

syndrome has not been described. Spontaneous, recurrent seizures as well as
long term remodeling and immunohistochemical changes have also not
been reported. Hilar cells containing GABA are mostly spared in the human
disease (Babb et al., 1989). However, these cells are relatively vulnerable to
ischemia (Ribak et al., 1985; Obenaus et al., 1993). It remains to be determined
whether these cells are spared in the kainate/ischemia model.
The Amygdala kindled rat model
Kindling is a very old technique that has been used traditionally to
induce the epileptic state in animal models of epilepsy.

This technique

involves repeated, daily use of low-voltage electrical stimulation of the
amygdala region until a state of enhanced sensitivity is attained (McNamara
et al., 1985). Seizure activity can then be elicited as desired with lower voltage
electrical stimulation.

Initial electrical stimulus as well as subsequent

stimulation in amygdala-kindled rats often elicits limbic type seizures
(Racine, 1972). Although inter-ictal spikes are observed on EEG, spontaneous,
recurrent seizures do not occur ordinarily without stimulation in kindled
animals.

In this sense, the kindling model fails to completely replicate the

clinical picture of the human disease (Klass, 1975). However, in more recent
studies, extended electrical kindling has been shown to lead to the
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development of spontaneous seizures (Milgram et al., 1995).
remain to be replicated.

These results

The pattern of neuronal cell death observed in

kindled animals is highly variable and appears to be dependent on the
number of seizure episodes. Brain damage may be limited to interneurons in
the dentate hilus or may evolve to include CA1

and eventually CA3

pyramidal cells depending on the number of repeated stimulation
(McNamara et al., 1985).

Long-term hippocampal remodeling has been

demonstrated for amygdala-kindled rats in the form of changes in dendritic
synapses in the medial amygdaloid nucleus (Okada et al., 1993); however, this
type of remodeling is dissimilar to the growth of new axonal systems
observed in the human pathology. Several authors have reported increase in
somatostatin levels in amygdala and various cortical regions in amygdala
kindled rats (Kato et al., 1983). This is in contrast to the decrease observed in
the human pathology.

The status of NPY and SP hilar interneurons is

unclear in either amygdala or hippocampus kindled rats.
The ouabain-potentiated, kainate rat model
Clearly, the limbic type behavioral seizures observed as well as
evidence from EEG point to the hippocampus and other limbic structures as
the focus of seizure activity in kainate/ouabain treated animals. An epileptic
state characterized by spontaneous, recurrent seizures supervenes in these
animals.

The pattern of cell damage produced with this model closely

replicates what is commonly observed in the human disease.

As in the

human pathology, all cells in Ammon's horn are damaged, but CA3 and CA1
pyramidal cells are significantly more affected than the granule and CA2
pyramidal cells.

Hippocampal remodeling in the form of mossy fiber

sprouting into the inner molecular layer is also present in this model.
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Finally, there is significant damage to cells in the dentate hilus, although it
remains to be determined whether this damage is selective for SOM, NPY,
and SP interneurons.
Unique features of this model compared to current animal models of
TLE are:

1. With intraperitoneal injections of kainate and ouabain, this

model is very easy to replicate. 2. This technique routinely produces damage
to cells of hippocampus area CA1; a lesion not always observed with other
animal models without a high animal mortality. 3. Treatment with ouabain
and kainate yields no animal mortality, as both drugs are administered well
below their toxicity levels.

4. Unlike many of the models described above,

brain damage in this model is confined to the hippocampus with minimal or
no extrahippocampal damage 5. Although not completely characterized, this
model more closely replicates the human pathology than many existing
models of TLE. 6. Finally, evidence from epileptic hippocampi for a role of
the Na+/K+ pump in the neuropathology of human TLE has been presented
(Grisar et al., 1992; Brines et al, 1995). Since this model is based on this very
concept, it may serve as a useful tool for investigating the role of the Na+/K+
pump in human TLE.
Although not extensively investigated in this model, recurrent,
spontaneous seizure episodes after the acute phase of kainate-induced
seizures has been well documented for most kainate rat models ( Ben-Ari et
al., 1981; Sperk, 1994). These studies have shown that spontaneous seizures
do not always recur after initial seizures with kainate. The reported rate is 50
- 60% (Cronin and Dudek, 1988). Optimum monitoring for chronic epilepsy
in these animals is best achieved by 24 hr video monitoring. This technique
was not used in this study; a less optimum technique (handling of animals to
induce seizures at time of observation) was used instead. This may explain

81
the rather low number of seizure episodes witnessed in the three animals
followed.

The latency to spontaneous seizure recurrence after kainate

treatment is at least a weak and may be delayed for up to several weeks (Pisa
et al., 1980; Cavalheiro et al., 1982; Tanaka et al., 1988). The first recurrence of
epileptic attacks after kainate/ouabain treatment in three animals occurred 14,
15, 30 days respectively, in agreement with previously published reports.
Finally, immunohistochemistry to characterize the subset of destroyed hilar
interneurons in this model was not successful, mainly due to technical
problems.

However, with the overwhelming damage to this region, some

damage of interneurons expressing

NPY, SP, and SOM is expected.

Confirmation of this criteria awaits further characterization of this model.
Anatomic basis and Pathway of Limbic seizures in rat hippocampus
Lothman and co-workers (1981) as well as others (Ben-Ari, 1985) have
postulated a pathway for generation and propagation of limbic seizures
(Figure 15; p. 84).

It is believed that area CA3 of the hippocampus is the

"pacemaker" for initiation and propagation of limbic seizures.

This is

supported by the finding that cells of area CA3 possess a low seizure threshold
(Schwartzkronin and Prince, 1978) . Cells in this area of the brain are also the
first to show an increase in metabolic activity in the early stages of seizure
activity (Nadler et al., 1981).

It is believed that heavy projections from the

hippocampus to the lateral septum are the first efferent projections activated
(Figure 15; bold lines).

This correlates with behavioral manifestations of

staring in the initial stages of seizure generation (Swanson and Cowan, 1977).
The second stage of limbic seizures is thought to involve non-hippocampal
limbic centers including the entorhinal cortex, the amygdala, subiculum, and
medial/lateral septum.

Increase in glucose utilization and detection of
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electrical activity in these areas correlate with automatisms and mild limbic
convulsions.

The third stage of limbic seizures is characterized by head¬

bobbing followed by bilateral fore-limb clonus and complete tonic-clonic
convulsions. During this stage, electrical activity and increased deoxyglucose
utilization have been recorded both in limbic and extralimbic areas as well as
on surface EEG leads.

It is believed that propagation of seizure activity to

these areas is along higher-order axons from secondary centers.

The

substantia nigra, midline thalamic nuclei and some paralimbic (olfactory,
perirhinal, periamygdaloid and cingular) cortical sites become activated.
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Figure 15
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Figure 15: Anatomic basis and pathway of kainic acid induced limbic seizures
The hippocampus is considered the principal brain area and its
afferent (dashed lines) and efferent (bold lines) are shown. Input to
the hippocampus is shown on the left and output is shown on the
right.

During the first stage of limbic seizures, the hippocampus

and lateral septum are selectively activated and the behavioral
response (lower part) is staring, when epileptic activity extendes to
non-hippocampal limbic areas (entorhinal cortex, amygdala,
subiculum and medial septum) mild limbic convulsions develop.
With extension along synaptic pathways from these secondary
limbic centers, extra-limbic centers are activated and severe limbic
convulsions appear. (Adapted from Lothman and Collins, 1981).
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CONCLUSION

Summary of findings:
1) Impairment of Na+/K+ pump capacity reduces neuronal survival of
excitatory stimuli in vivo. Thus kainate (5 mg/kg; ip) or ouabain (1 mg/kg;
i.p) do not typically cause seizures or neuronal injury in animals. However,
kainate (5 mg/kg; i.p.) combined with ouabain (3 nmoles; i.c.v) reliably
induces seizure activity and neuronal injury in rat hippocampus.

Similarly,

ouabain (1 mg/kg; i.p.) or kainate (7 mg/kg; i.p.) do not ordinarily induce
seizures or neuronal injury in animals; however,

a combination of these

treatments induces seizures and hippocampal damage. A strong association
was observed between Na+/K+ pump inhibition and kainate treatment in
producing seizures and subsequent neuronal damage.

Thus, when ouabain

(3nmoles; i.c.v) is delayed (90 min instead of 30 min) after kainate (5 mg/kg;
i.p.) seizure onset is also delayed and the duration of seizures is reduced,
although latency to seizure onset after ouabain injection remains unchanged.
2) Treatment with the combination of kainate and ouabain induces a
seizure syndrome and neuropathology similar to human TLE. The following
features are produced:
A. Acute limbic seizures originating from the hippocampus.
B. Spontaneously recurring chronic seizures beginning 14 - 30 days (n
=3) after initial treatments.
C. Damage to hippocampal cells in a pattern reminiscent of the human
pathology.
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D. Hippocampal remodeling in the form of mossy fiber sprouting into

the dentate gyrus.
In conclusion, impairment of Na+/K + pump capacity decreases
neuronal ability to survive excitatory activity and a pathology is produced
that closely replicates human TLE. To the best of our knowledge, this is the
first report of an animal pathology of human TLE produced by the method
described herein.

This model has been termed the ouabain-potentiated,

kainate (OPK) model of TLE.
Clinical relevance:
Our observation with direct pharmacological reduction of rat total
Na + /K+ pump capacity has implications for human disease, since cardiac
glycosides are widely used to treat congestive heart failure and cardiac
arrhythmia.

Although these drugs penetrate the CNS poorly, neurological

manifestations are nonetheless side-effects of treatment (Cooke, 1993).

In

contrast to rodent isoforms, all three human isoforms of the Na+/K+pump
possess high affinity binding for cardiac glycosides (Sweadner, 1989). Thus,
neurotoxic threshold for glycosides may be much lower for human than for
rodents.

Epileptic patients in treatment for cardiac disease with glycosides

may be particularly vulnerable to this potential complication, as Na+/K+
pump activity may already be reduced in these patients (Grisar and DelgadoEscueta, 1986; Brines et al., 1995)
Finally, results of the present study are consistent with existing
evidence suggesting that Na+/K+ pump capacity may be insufficient or
comprised in the epileptic hippocampi (Grisar, 1984; Lees, 1991; Brines et al.,
1995). Thus, it can be hypothesized that seizure generation and the sequelae
of neuronal injury may be prevented or ameliorated by upregulating Na+/K+
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pump capacity in the hippocampus.

Some evidence exist to suggest that

Na+/K+ pump expression can be modulated both in vitro and in vivo. Mata
and

coworkers

have

demonstrated

that

prolonged

stimulation

of

hypothalamic neurons leads to isoform specific up-regulation of Na+/K+
pump mRNA (Mata et al., 1980).

Such isoform-specific upregulation of

Na+/K+ pump capacity have also been reported for CA1 and CA4 pyramidal
cells exposed to the mineralocorticoid, aldosterone (Farman et al., 1994). Also,
up-regulation of neuronal Na+/K+ pump activity by treatment with insulin
and insulin like growth factors (IGF) has recently been reported.

This

upregulation was associated with increased survival of glutamate toxicity in
vitro (Swanson and Choi, 1993). This last finding suggest that further study of
Na+/K+ pump regulation may lead to methods of ameliorating or preventing
the hyperexcitability and neuronal damage intrinsic to the pathology of
human epilepsy.
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